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 Heart failure and cardiac fibrosis 
Heart failure and cardiac fibrosis are two pathological processes, that cannot be assessed 
isolated from one another. Heart failure can be either cause or consequence of cardiac 
fibrosis and vice versa. Depending on the initial condition cardiac fibrosis can be divided 
into a reactive and a reparative type. In case of myocardial infarction reparative cardiac 
fibrosis occurs to prevent ventricular rupture. The sudden death of a huge amount of 
cardiomyocytes causes the release of growth factors and cytokines, such as transforming 
growth factor β1 (TGF-β1) and interleukin 4 (Il-4) (Peng et al. 2015), thus leading to the 
initiation of reparative fibrosis, which can be considered as a replacement fibrosis at the 
previous site of the necrotic cardiomyocytes. This process aims to maintain the structural 
integrity of the injured heart. However, the formation of fibrotic tissue subsequently causes 
an impairment of the contractile cardiac function (Segura et al. 2014).  
In contrast, in response to pressure overload, for example due to hypertension or aortic 
stenosis, the overt neuro-humoral stimulation of cardiac cells induces reactive cardiac 
fibrosis (Kong et al. 2014). Over time the accumulation of extracellular matrix (ECM) in the 
myocardium triggers cardiomyocyte death and thus systolic heart dysfunction due to an 
insufficient perfusion of the muscle. This then drives reparative fibrotic processes. The 
imbalance between ECM production and degradation leads to an increase in cardiac 
stiffness thus additionally causing diastolic dysfunction. Since perfusion of the myocardium 
mainly takes place during relaxation in diastole, it is seriously compromised. Consequently, 
more cardiomyocytes decay and the inflammation and the consecutive remodelling 
continue in a vicious circle. A further consequence of the replacement of cardiomyocytes 
by extracellular matrix is the uncoupling of neighbouring cardiomyocytes and therefore the 
disruption of the syncytium by uncoupling. As propagation of the electrical excitation and 
the coordinated contraction is disturbed by the presence of the isolating matrix, arrhythmias 
can occur (Berk et al. 2007; Stein et al. 2010).  
So far cardiac fibrosis cannot be halted or reversed. The interplay in this process between 
the different cardiac cells is complex and is currently a matter of intense research. In 





 Cardiac fibroblasts 
The healthy adult heart contains a considerable number of quiescent fibroblasts. Due to 
their dynamic phenotype and their different developmental origins, the determination of 
exact numbers is difficult. More recent studies suggest that, after endothelial cells, cardiac 
fibroblasts account for the second most abundant non-myocyte cell type in the heart (Pinto 
et al. 2016).  
Cardiac fibroblasts are embedded in a mesh of interstitial cardiac matrix and react to 
chemical and mechanical stimuli, making them sentinel cells in the myocardium. The 
surrounding matrix contains, in addition to structural components, bioactive molecules such 
as proteases and growth factors, which are secreted by cardiac fibroblasts and other 
cardiac cells. Cardiac fibroblasts can be activated quickly after cardiac damage due to 
manifold changes in their environment. This induces their transdifferentiation into 
myofibroblasts and subsequently the fibrotic process (Kong et al. 2014). Myofibroblasts can 
be distinguished by different features and are termed myofibroblasts due to similarities with 
smooth muscle cells. Myofibroblasts possess prominent microfilaments and expresses α-
smooth muscle actin, the typical actin isoform in vascular smooth muscle cells (Bochaton-
Piallat et al. 2016). By this myofibroblasts gain the ability to develop contractile forces. Thus, 
myofibroblast activation and reaction leads to wound contraction and results in a collagen-
based scar for example following myocardial infarction. 
It has been suggested, that the main source of myofibroblasts during tissue repair after 
myocardial infarction are proliferating resident fibroblasts (Yano et al. 2005). However, other 
origins may also contribute to the myofibroblast population. Bone marrow-derived cells, also 
called fibrocytes, are another well documented source of myofibroblasts (Möllmann et al. 
2006; Chu et al. 2010). In addition, epicardial epithelial and vascular endothelial cells 
undergoing respectively an epithelial- and endothelial-mesenchymal transition (EMT, 
EndMT), and pericytes are also known sources of cardiac myofibroblasts (Zhou and Pu 
2011; Wu et al. 2013; Montorfano et al. 2014). 
Irrespective of their origin, myofibroblasts secrete more factors than quiescent cardiac 
fibroblasts. This includes not only structural components such as collagens, but also 
cytokines. The latter drive the intense inflammatory process and the recruitment of other 
cells, which finally contributes to the pool of cardiac myofibroblasts (Fig.1). As a 
consequence, the balance of ECM production and degradation is shifted towards its 





Figure 1: Schematic overview of cardiac fibrosis. Upon a stimulus associated with cardiac 
damage, an inflammatory reaction is triggered. Mediators such as TGF-β1 and Il-4 are released and 
stimulate the transdifferentiation of fibroblasts to myofibroblasts. The activated myofibroblasts 
produce extracellular matrix, contributing to fibrotic replacement of the dead cardiomyocytes and 
resulting in scar tissue and cardiac fibrosis.  
One of the problems in analysing cardiac fibroblasts is the lack of specific markers. Various 
markers have been discussed, but so far none of them is well-established. The problem in 
finding an adequate marker has several reasons: cardiac fibroblasts can be derived from 
various sources and additionally, cardiac fibroblasts undergo significant changes upon their 
activation, as described before. This influences the proteome and thereby the pattern of 
marker expression (Matthijs Blankesteijn 2015). During development, signalling mediated 
via platelet derived growth factors (PDGF) α/β play an important role. The receptor PDGFR-
α can be used as a marker for mesenchymal cells, to which fibroblasts belong (Olson and 
Soriano 2009). However, it was recently shown that the newly identified interstitial telocytes 
in the myocardium can be also characterised by PDGF receptor expression. Fibroblast 
activation protein alpha (FAP) has also been suggested as a marker for activated fibroblasts 
(Tillmanns et al. 2015) however quiescent fibroblasts would, in this case, not be detected. 
One further potential marker is fibroblast-specific protein 1 (FSP-1). But FSP-1 lacks 




smooth muscle cells as well. A more suitable marker is periostin, which marks cells 
morphologically compatible with myofibroblasts, but which was not detected in quiescent 
cardiac fibroblasts (Kong et al. 2013). Periostin was found to be expressed in connective 
tissue cells facing mechanical stress (Horiuchi et al. 1999). Accordingly, it can be found in 
activated cardiac fibroblasts. Transcription factor 21 (TCF-21; epicardin/Pod1/capsulin) 
belongs to the basic helix-loop-helix (bHLH) family of transcription factors and has been 
shown to be required for the epithelial-mesenchymal transition. It marks fibroblasts, but can 
also be found in coronary vascular smooth muscle cells (Acharya et al. 2012). 
Identifying fibroblasts remains a critical topic, since the current known markers are either 
restricted to activated or quiescent fibroblasts, do not sufficiently detect fibroblasts from 
different origins or are not specific and expressed in other cells types as well. Hence, the 
identification of these cells is based on morphological criteria. They possess a spindle-
shaped cell body, from which several processes branch out. In addition, fibroblasts are 
characterised by their Golgi apparatus and rough endoplasmic reticulum, which are very 
prominent (Souders et al. 2009). These traits are probably due to the high protein synthesis 
and secretion activity.  
Their highly dynamic character and crucial role in the development of cardiac fibrosis make 
cardiac fibroblasts a prime target for research in the field of heart failure. A better 
understanding of cardiac fibroblast is the key to preventing unnecessary development of 
collagen scars, or even to reverse pathological cardiac remodelling.  
 Primary cilia 
 Microtubule structures form primary cilia 
Primary cilia are cellular structures largely composed of a microtubule skeleton. In contrast 
to motile cilia, which are composed of 9 outer microtubule doublets and one doublet in the 
middle, primary cilia lack the core microtubule doublet and the surrounding proteins, which 
enable motile cilia, such as flagella, to produce motility (Satir et al. 2010). Thus, primary 
cilia are considered immotile microtubule structures, with the exception of primary cilia 
found at the embryonic node (Kim and Dynlacht 2013).  
Figure 2 illustrates the structure of primary cilia, which emanate from the cell surface as 
solitary structures, covered by the plasma membrane. The primary cilium itself is built by 




The primary cilium’s axoneme extends from a basal body, that is derived from the mother 
centriole (Marshall 2007), which is prior to ciliogenesis part of the centrosome and 
microtubule organising centre. Several changes distinguish the basal body from the mother 
centriole. Among those basal body specific features are transition fibers, which aid the 
docking of the basal body to the ciliary membrane (Veland et al. 2014).  
 
Figure 2: Schematic presentation of primary cilia structure. A) Schematic longitudinal section of 
a primary cilium. The primary cilium consists of a microtubule-based cytoskeleton covered by the 
ciliary membrane, which invaginates at the basis to form the ciliary pocket. Transition fibers connect 
the basal body to the ciliary pocket. B) Schematic horizontal section of microtubule structures of the 
ciliary axoneme (upper image) and of the basal body (below). The shaft of the cilium is composed of 
9 outer microtubule doublets and transforms into 9 triplets in the basal body (adapted from 
Schimmack et al. 2016). 
The microtubule doublets stabilising the ciliary shaft are composed of protofilaments. 
Thirteen protofilaments form a hollow microtubule cylinder and two of those cylinders build 
one microtubule doublet. The basis of the protofilaments are polymerised α- and β-tubulin 
dimers. As further described in section 1.4, α-tubulin undergoes various post-translational 
modifications, among them the intraluminal acetylation. Therefore, antibodies against 
acetylated α-tubulin can be used to visualise the primary cilium’s shaft by 
immunofluorescence. A paralogue of α- and β-tubulin is γ-tubulin, which can be found in the 
basal body. In complexes with other proteins, γ-tubulin facilitates microtubule nucleation 




assembly are needed. To identify primary cilia structures the detection and characteristic 
co-localisation of α- and γ-tubulin in the shaft and the basal body, respectively, can be used.  
 Regulation of primary cilia formation and length 
A substantial number of factors has been reported to contribute to primary cilia formation 
and length regulation.  
One process that is crucial for primary cilia formation and maintenance, is intraflagellar 
transport (IFT) (Kozminski et al. 1993). Structures such as cilia and flagella are subjected 
to constant turnover. For this, a continuous input of α- and β-tubulin subunits is required to 
maintain length (Marshall and Rosenbaum 2001). In consequence, the assembly and 
disassembly of microtubule structures, such as the axoneme of cilia, demands the presence 
of soluble tubulin, which can be incorporated into the distal end of the cilium. Taxol, which 
inhibits depolymerisation of microtubules leads to a reduction of soluble tubulin subunits 
and thereby decreases length of cilia and flagella (Sharma et al. 2011).  
Moreover, inhibition of actin polymerisation caused by cytochalasin D has been 
demonstrated to elongate cilia and support ciliogenesis. The actin-related protein ACTR3, 
which is required for actin polymerisation, was found to be an important regulator of 
ciliogenesis as its knockdown led to an elongation of primary cilia (Kim et al. 2010).  
Primary cilia are regulated by environmental stimuli, for example by hypoxia. In vivo hypoxia 
can be caused by various different conditions, such as ischemia or injury. The processes of 
tissue impairment and reparation are complex, although hypoxia can be considered as one 
of the main factors contributing to the demise of cells. A change in primary cilia length has 
been documented for example upon tubular injury (Verghese et al. 2008). In this context it 
was demonstrated, that cobalt chloride, which stabilises hypoxia inducible factor alpha 
(HIF1-α), led to an elongation of primary cilia in Madin Darby canine kidney cells (Verghese 
et al. 2011). Which consequences this elongation of primary cilia under hypoxia has, 
remains to be elucidated.  
Another substance that is known to increase primary cilia length is lithium chloride. The 
exact mechanism by which the mood stabiliser causes this effect, has yet to be elucidated. 
It is likely, that the mechanism is mediated via the glycogen synthase kinase 3β (GSK-3β) 
(Klein and Melton 1996). Various downstream pathways of GSK-3β inhibition are under 




factors have been shown to influence primary cilia length, but these will not be discussed 
further, as they are beyond the scope of this thesis.  
 
Figure 3: Factors that contribute to primary cilia length. Scheme of positive and inhibitory effects 
on the length of primary cilium. Hypoxia and LiCl are highlighted, both factors were analysed in the 
performed experiments.  
 The primary cilium as a sensory organelle 
Primary cilia can fulfil a variety of functions, including a role as mechanosensors. A 
mechanical stimulus, e.g. fluid flow, first leads to a deflection of the cilium. For renal 
epithelium it has been shown that fluid flow initiates an intracellular calcium signal, which 
can also spread to surrounding cells, presumably via gap junctions (Praetorius and Spring 
2001). The ability and sensitivity of primary cilia to react to fluid flow increases with 
enhanced ciliary length (Resnick and Hopfer 2007). On the other hand, flow was 
demonstrated to influence primary cilia formation. The endothelium, for example, carries 
primary cilia especially in regions with reduced or disturbed flow. These regions are 
susceptible to atherosclerosis (Conway und Schwartz 2013).  
One of the channels thought to play a key role in the calcium signalling of primary cilia is 
polycystin-2 (PC2). It belongs to a subfamily of the transient receptor potential (TRP) 
channels and is mainly located at the membrane of the endoplasmic reticulum (Koulen et 
al. 2002). Another example for TRP channels can be found in primary cilia of neurons in 
Caenorhabditis elegans (C. elegans). Here TRPV (TRP of the vanilloid family) channel 
proteins were found to be important for sensory transduction and adaptation. In addition to 
their mechanosensory function, TRP channels in cilia of sensory neurons in C. elegans  
react to chemical stimuli such as high osmolarity (Tobin et al. 2002). Besides their role in 
mechanosensing, primary cilia also serve as environmental sensors for light and odorant 




 Primary cilia play a role in different tissues and their dysfunction plays 
a role in various diseases  
The importance of primary cilia becomes especially obvious by the variety of tissue and 
organ deficiencies associated with ciliary defects.  
One example for a genetic ciliopathic disorder in humans is the Bardet-Biedl-Syndrome 
(BBS). It is caused by defects in the genes encoding the BBS proteins, which are important 
for the function of cilia and the basal body (Ansley et al. 2003). The BBS comprises a variety 
of symptoms, including retinopathy, obesity, polydactyly, hypogonadism, cognitive 
impairment and polycystic kidneys. The involvement of other organ systems has also been 
reported, e.g. congenital heart defects (Elbedour et al. 1994).  
In respect to the classification as ciliopathy, the proteins BBS-7 and BBS-8 have been 
shown to play key roles in the process of IFT and their loss of function results in cilia defects 
(Blacque et al. 2004). In addition, mutations in BBS-genes have been shown to lead to 
defects in mechano- and thermosensation in mice, probably caused by the dysfunction of 
cilia in sensory neuron of the skin (Tan et al. 2007).  
Another rare genetic disorder, which belongs to the group of ciliopathies and shows 
similarity in its symptoms to the BBS, is the Alstrom syndrome. The underlying defect is a 
mutation of the ALMS1 gene. The encoded protein localises to ciliary basal bodies and a 
mutation in the ALMS1 gene has been shown to cause impaired cilia in kidney epithelial 
cells in mice (Li et al. 2007). Interestingly, autopsies of patients with Alstrom syndrome 
revealed fibrosis of various organs, for example of liver and kidney (Marshall et al. 2005). 
This raises the question of a potential role of defect cilia in the development of organ fibrosis.  
Other proteins, localised to primary cilia, are polycystin-1 (PC1) and -2 (PC2). Defects in 
those proteins lead to autosomal dominant polycystic kidney disease (ADPKD). Primary 
cilia on kidney epithelial cells are important for a downright tissue morphogenesis. Hence, 
a defect of PC1 or PC2 leads to an impaired mechanosensation and results in the 
development of multiple renal cysts (Nauli et al. 2003).  
Loss of function of primary cilia has also been related to tumorigenesis, such as the 
development of ovarian cancer (Egeberg et al. 2012), cholangiosarcoma (Gradilone et al. 




 Primary cilia in the heart 
Primary cilia at the embryonic node are involved in the formation of the left-right body 
asymmetry by facilitating a laminar nodal flow (McGrath and Brueckner 2003). This 
asymmetry determines the distribution of whole organs, such as the liver and the stomach. 
It is also important for proper development of the heart, which is asymmetric in itself and in 
correlation to its connecting vessels (Koefoed et al. 2014). 
In addition, primary cilia are involved in cardiomyocyte differentiation. Important 
components of the hedgehog signalling pathway, which plays a role in the development of 
various cell types, localise to the primary cilium, which thus contributes to cardiogenesis 
(Clement et al. 2009). Cardiac primary cilia also coordinate TGF-β signalling during 
cardiomyogenesis (Koefoed et al. 2014). 
Apart from those findings referring to the developmental role of primary cilia in the heart, it 
can also be speculated that their versatile sensory abilities and involvements in signalling 
pathways may be of importance in the adult heart as well. 
 Tubulin acetylation 
 Post-translational acetylation of α-tubulin 
After incorporation into microtubules, tubulin undergoes different post-translational 
modifications. Among them phosphorylation (Eipper 1974), detyrosination (Barra et al. 
1973), glutamylation (Edde et al. 1990), glycylation (Redeker et al. 1994) and acetylation 
(L’Hernault und Rosenbaum 1983). The last one stands out since the α-tubulin-acetylation 
is the only modification which is located at the intraluminal side of the microtubules (Soppina 
et al. 2012).  
This intraluminal acetylation takes place at the ε-amino-group of lysine 40 (K40) of α-tubulin 
and is catalysed by α-tubulin-N-acetyl-transferase (ATAT1) (Shida et al. 2010). ATAT1 
transfers the acetyl group of acetyl Co-enzyme A to K40 of α-tubulin. The adversary of the 
acetyl-group transferring ATAT1 is the histone deacetylase 6 (HDAC6), which possesses 
the capacity to cleave acetyl groups from histones, but which is also the main deacetylase 
of α-tubulin. 
Increased levels of acetylated tubulin can be detected in long-lived microtubules, that are 





 HDAC6 and its inhibition  
There are 4 classes of histone deacetylases, grouped based on their sequence homology. 
Class I, II and IV HDACs gain their catalytic activity via a zinc-binding domain. HDAC6 is a 
class IIb histone deacetylase which is located in the cytoplasm and contributes to the 
regulation of tubulin stability and thus influencing mitosis (Hubbert et al. 2002). HDAC6 had 
been detected in higher density at the basal body of primary cilia and was found to be 
associated with their disassembly (Ran et al. 2015). Gradilone et al. have shown, that 
overexpression of HDAC6 in cholangiosarcoma cells induced deciliation in cholangiocytes, 
which in consequence led to a higher proliferation rate of those cells. This increased 
proliferation capacity could be reverted by the knockdown of HDAC6 and by HDAC6 
inhibition with tubastatin A (Gradilone et al. 2013).  
HDAC inhibitors have been used in cancer therapy for a while (Secrist et al. 2003). Using 
unspecific HDAC inhibitors bears a high risk of undesirable side effects. For this reason, the 
development of specific HDAC inhibitors is a current target in research. With tubastatin A, 
a highly specific HDAC6 inhibitor has been developed (Butler et al. 2010). Tubastatin A was 
shown to have neuroprotective (Zhang et al. 2014b) and anti-inflammatory effects 
(Vishwakarma et al. 2013) and is thought to be a promising therapeutic drug. Moreover, a 
certain role of HDAC6 in pathological cardiac remodelling can be assumed, since it has 
been demonstrated, that HDAC6 inhibition prevents the contractile dysfunction as a 
consequence to tachypacing (Zhang et al. 2014a).  
The combination of the anti-proliferative and anti-inflammatory effect of HDAC6 inhibition 
by tubastatin A and its impact on the prevention of contractile dysfunction, directs the focus 
on the role of HDAC6 in cardiac fibroblasts, too. 
 ATAT1 and its mobilisation by lithium chloride 
ATAT1 is the major acetyl-transferase in mammals (Kalebic et al. 2013). The enzymatic 
transfer rate of ATAT1 is relatively low due to the position of the enzymatic binding. 
Therefore, only stabile microtubule structures possess a considerable amount of acetylated 
α-tubulin (Szyk et al. 2014).  
It has been shown in human fibroblast KD cells that ATAT1 can be mobilised by treatment 
with lithium chloride. Lithium chloride is used in the clinic as a mood stabiliser in prevention 
of bipolar disease. The mobilisation of ATAT1 is probably mediated via the inhibition of the 




In consequence, the acetylation of α-tubulin is increased and primary cilia are elongated 
(Nakakura et al. 2015). 
 
Figure 4: Acetylation of α-tubulin. ATAT1 transfers an acetyl group from acetyl-CoA to the ε-






 Aim of the project 
Cardiac fibrosis impairs cardiac function and leads to heart failure. Understanding its 
pathogenesis and the mechanisms behind the pathological cardiac remodelling will help to 
identify targets for anti-fibrotic treatment and thus improve quality of life and prognosis of 
patients with heart failure.  
Cardiac fibroblasts play a central role in cardiac fibrosis and thus are the key to new 
therapeutic approaches. They possess the ability to react to chemical and mechanical 
stimuli. As sensory organelles, primary cilia contribute to such environmental adaptations 
in other cells. 
The first part of the project was to investigate whether cardiac fibroblasts from different 
species and maturation states possess primary cilia in 2D cultures. If so, we then wished to 
address whether primary cilia are present in homogenous and heterogeneous 3D cultures 
of cardiac fibroblasts. 
Acetylated α-tubulin marks stabilised microtubule structures and an increase in acetylated 
α-tubulin, either as consequence of a knockdown of the monomeric GTPase RhoA or 
induced by inhibition of HDAC6 with tubastatin A, had been found in cardiac fibroblasts in 
former studies of the group of Professor Lutz (Jatho et al. 2015). Hence, the regulation of 
tubulin acetylation in cardiac fibroblasts and its impact on primary cilia regulation were 
studied more intensely during this project. For this, in addition to the effect of tubastatin A 
as a specific HDAC6 inhibitor, the influence of lithium chloride was elucidated. In addition, 
as an important environmental change occurring in the diseased heart, the effect of hypoxia 
on primary cilia regulation was part of the proposed project. 
 
Finally, the changes in tubulin acetylation and primary cilia regulation on a biological 





2 Materials  
 Animals 
Wistar-Kyoto Rats, Charles River, Sulzfeld 
NMRI mice, Zentralinstitut für Versuchstierzucht, Hannover 
Wild type C57BL/6J adult mice, Charles River, Sulzfeld 
 Cells 
Neonatal rat cardiac fibroblasts (NRCF), see method section 3.1.1 and 3.1.2 for detailed 
isolation procedure 
Neonatal mouse cardiac fibroblasts (NMCF), see method section 3.1.1 and 3.1.3 for 
detailed isolation procedure 
Adult mouse cardiac fibroblasts (AMCF), see method section 3.1.4 for detailed isolation 
procedure 
Normal human cardiac fibroblasts (ventricle, NHCF-V), Cat. No. CC-2904, Lonza 
 Chemicals, reagents and consumables 
Table 1: Fine chemicals and reagents 
Reagent Company 
10% Triton X-100 Carl Roth 
Acrylamide solution rotiphorese gel 30 Carl Roth 
Ascorbic acid  AppliChem 
BrDU  
DAPI (4',6-diamidino-2-phenylindole)  Sigma-Aldrich 
Fluoromount Sigma-Aldrich 
Igepal CA-630  Sigma-Aldrich 
Lithium chloride Sigma-Aldrich 
Lumi‐LightPLUS western blotting substrate Roche 
Neonatal heart dissociation kit, mouse and rat Miltenyi Biotec 
Paraformaldehyde (PFA)  Sigma-Aldrich 
PhosphoSTOP phosphatase inhibitor cocktail 
tablets  
Roche Applied Science 
Ponceau-S  Sigma-Aldrich 
Protein marker „Roti‐Mark Standard“ Carl Roth 
Roti‐Block (blocking reagent) Carl Roth 




Tetramethylethylenediamine (TEMED)  Merck 
TRITC‐phalloidin Sigma-Aldrich 
Triton X-100  Carl Roth 
Tubastatin A Sigma-Aldrich 
Tween-20  Carl Roth 
Table 2: Consumables 
 Specification Company 
Cell culture flasks  T25, T75, T175 Sarstedt 
Cell culture plates  6 cm, 10 cm, 15 cm  Sarstedt 
Cell culture multi well plates 6 well, 12 well  Sarstedt 
Cell culture multi well plates 24 well Greiner Bio One 
Cell scraper 1.7 cm blade Sarstedt 
Microscope slides  24 x 50 mm, Menzel Thermo Scientific 
Cover slips   18 mm Ø, Menzel Thermo Scientific 
Filter Tips   10 µl, 100 µl, 1000 µl Greiner Bio One 
gentleMACS   C tubes Miltenyi Biotec 
Microscope cover glasses 22 mm Thermo Scientific 
Multi tips   2 ml, 5 ml, 10 ml Eppendorf 
Nitrocellulose membrane, 
Protran    
Pore size 0.2 μM Whatman,  
GE Healthcare 
Pipette tips   10 µl, 100 µl, 1000 µl Sarstedt 
Rat EHM/ECT molds   
  
Inner diameter 8 mm, 
outer diameter 16 mm, 
depth 5 mm, 
2 moulds per 50 mm glass 
dish 
Internal production of the 
Institute of Pharmocology 
and Toxicology, UMG 
Sterile pipettes 
  
2 ml, 5 ml, 10 ml, 25 ml Sarstedt 
Reaction and centrifuge 
tubes  
15 ml, 50 ml Greiner Bio One 
Wide opening, serological 
pipettes    





Table 3: Devices 
Device Type Company 
Autoclave  VX-150  Systec  
Automated multiparameter 
cell analysis machine  
Cellavista SynenTec 
Blotting chamber  Mini Trans-Blot Cell Bio-Rad Laboratories 
Cell counter and analyzer CASY Model TTC Roche 
Cell counting chamber  Neubauer Labor Optik 
Cleanbench  Hera Safe KS 12 Thermo Electron 
Centrifuges Centrifuge 5804R Eppendorf 
Megafuge 3.OR Heraeus Sepatech 
Chemiluminescence imager ChemiDoc MP Biorad 
Confocal microscope 
Microscope objective 10x  
Microscope objective 20x 
Microscope objective 63x 





Zeiss LSM 710 
Zeiss LSM 710 
Zeiss LSM 710 
gentleMACS   Dissociator Miltenyi Biotec 
Gel electrophoresis 
chamber 




Microscope filter blue 
Microscope filter red 
Microscope filter green 
Microscope objective 4x 
Microscope objective 10x 
Microscope objective 20x 
Microscope objective 40x 































Heating plate (magnetic) RCT basic Janke u. Kunkel IKA 
Labortechnik  
Incubators Cell culture, 37°C, 5% CO2 Labotec 
CB159 Binder, Tuttlingen 
Large scale shaker Innova 4300 Eppendorf 
Oxygen-controlled 
workstation 
Sci-tive Baker Ruskin 
Technologies, Bridgeend, 
UK 
pH meter Inolab pH Wtw 
Rotation shaker Reax 3 Heidolph 
Shaker  3016 GFL 
Sterile hood Telstar Bio II A Prettl 
Table centrifuge Centrifuge 5415D Eppendorf 
Vibratome Leica VT1000S Leica 
Vortexer VF2 W. Krannich 
 
 Cell culture media and additives 
Table 4: Additives for cell culture 
Reagent Company 
10x DPBS (Dulbecco’s phosphate buffered saline),  
w/o calcium and magnesium chloride  
Life Technologies 
CASYton OLS OMNI Life Science 
Chicken embryo extract (CEE) Self-made 
Collagen I (rat tail) own production 
DMEM (Dulbeccos modified eagle medium) powder 10x BD Biosciences 
DMEM/F12 Glutamax, Cat-No. 31331-028  Life Technologies 
DMEM GlutaMAX 1 g/l glucose, pyruvate 
Cat-No. 21068-028 
Life Technologies 
DMEM GlutaMAX, 1 g/l glucose  
Cat-No. F 04150 
Biochrom 
DMEM GlutaMAX 4.5 g/l glucose 
Cat-No. 42430-025 
Life Technologies 
DPBS (Dulbecco’s phosphate buffered saline),  





Fetal bovine serum (FBS)  Life Technologies 
Fibroblast growth medium-3 (FGM-3) BulletKit (CC-3131 
& CC-4525) 
Lonza 
Horse serum  Life Technologies 
Matrigel basement membrane matrix BD Biosciences 
Non-essential amino acids (NEAA), 100x Life Technologies 
Penicillin-streptomycin (P/S), 100x  
(10000 U/ml penicillin, 10000 µg/ml streptomycin)  
Life Technologies 
Trypan blue (0.4%)  Fluka  
TrypLE Express Life Technologies 
Trypsin-EDTA (0.05%) Life Technologies 
Table 5: Cell culture media and solutions 
Isolation of neonatal cardiac cells 
Calcium and bicarbonate free Hank’s 
with HEPES (CBFHH) 
40 ml NaCl stock (200 g/l) 
10 ml MgSO4 stock (20 g/l) 
10 ml KH2PO4 stock (6 g/l) 
10 ml Na2HPO4 2 H2O (5.95 g/l) 
10 ml Glucose dehydrate stock (100 g/l) 
ddH2O up to 1l, sterile filtered, pH 7.4 with 
NaOH 
Heat-inactivated FBS 50 ml FBS were incubated in a water bath 
at 56°C for 30 min 
Non-cardiomyocyte medium (NCM) 
 
DMEM GlutaMAX 1 g/l glucose 
10% FBS (v/v, heat-inactivated) 
1% P/S (v/v) 
Neonatal heart dissociation kit, mouse 




Enzyme A (reconstituted with 1 ml buffer A) 
Enzyme D (reconstituted with 3 ml DMEM) 




Neonatal mouse cardiomyocyte medium 
(NMCM) 
DMEM GlutaMAX 1 g/l glucose, 3.7 g/l 
NaHCO3 
10% FBS (v/v) 
1% P/S (v/v) 
1% BrDU 
NRCF/NMCF culturing 
Growth medium DMEM GlutaMAX 4.5 g/l glucose 
10% FBS active (v/v) 
1% P/S (v/v) 
1% NEAA (v/v) 
Serum-depleted medium DMEM GlutaMAX 1 g/l glucose 
1% P/S (v/v) 
1% NEAA (v/v) 
Generation of engineered cardiac fibroblast tissue from NRCF (ECT) 
2x DMEM 20% 10x DMEM  
20% FBS (v/v) 
2% P/S (v/v) 
in ddH2O, sterile filtered 
Generation of engineered heart muscle from NRCF (EHM) 
EHM medium DMEM, 1g/l glucose, NaHCO3 
11.6% Horse serum 
2.3% CEE 
1% P/S (v/v) 
AMCF culturing 
Growth medium DMEM/F12 GlutaMAX 
10% FCS active (v/v) 
1% P/S (v/v) 
100 µM Ascorbic acid 
HVCF culturing 
Growth medium FGM-3 basal medium 
0.1% rhFGF-β (r-human FGF- β) 
0.1% Insulin 





 Buffers and solutions 
Table 6: Buffers and solutions 
Immunofluorescence 
4% Paraformaldehyde (PFA) 40 g Paraformaldehyde 
200 µl 10 N NaOH 
100 ml 10x DPBS 
pH 7.0 with HCl,  
ddH2O to 250 ml 
0.2% Triton X-100 1 ml 10% Triton X-100 
DPBS to 50 ml 
1x Roti block 5 mL Roti-Block 
ddH2O to 50 ml 
Blocking and permeabilization buffer 
for immunostaining of samples on 
cover slips 
5 ml FCS 
1 ml 10% Triton X-100 
DPBS to 50 ml 
Blocking and permeabilization buffer 
for immunostaining of vibratome 
sections 
5 ml Roti-block 
1 ml 10x Triton X-100 
ddH2O to 50 ml 
SDS-PAGE and immunoblot 
Lysis buffer (GST-Fish) 50 mM Tris 
150 mM NaCl 
2 mM MgCl2 
10% Glycerol (v/v) 
1% Igepal CA-630 (v/v) 
pH 7.4 with HCl 
ddH20 to 1 l 
Phosphatase inhibitor cocktail added prior to use 
4x SDS-PAGE sample buffer w/o 
glycerol 
1% β-Mercaptoethanol (v/v) 
200 mM Tris (7.4) 
5.7 g SDS 
0.2 g Bromophenol blue 
in ddH2O, pH 7.4  
10% APS 1 g APS 




10% SDS 10 g SDS 
ddH2O to 100 ml 
5x SDS-PAGE buffer 30.2 g Tris 
188 g Glycine 
10 g SDS 
pH 8.3 with HCl  
ddH2O to 2 l 
1x SDS-PAGE buffer 400 ml 5x SDS-PAGE buffer 
ddH2O to 2 l 
1x Immunoblot buffer 6 g Tris 
28.8 g Glycine 
400 ml Methanol 
H2O to 2 l, pH 8.4 
10x Tris-buffered saline (TBS) 24.2 g Tris 
175.3 g NaCl 
pH 7.4 with HCl  
ddH2O to 2 l 
1 x TBS with tween-20 (TBST) 200 ml TBS 
2 ml Tween-20 
ddH2O to 2 l 
Ponceau-S solution 0.2 g Ponceau-S 
3 ml Acetic acid 
ddH2O to 100 ml 
 
 Antibodies 




Dilution Species Clone Company 
WB IF 
β-actin 
   





Caveolin-3 - 1:500 Rabbit Polyclonal, 
ab2912 
Abcam 
CD31 - 1:100 Rabbit Polyclonal, 
ab28364 
Abcam 





1:2000 1:1000 Mouse monoclonal/ 
6-11B-1, T6793  
Sigma-Aldrich 
γ-Tubulin 1:100 1:500 Rabbit Polyclonal/T3559 Sigma-Aldrich 
 
Table 8: Secondary antibodies for immunoblot analyses 
Secondary antibody against Dilution Species Cat No./Company 
anti-mouse-IgG-horse-radish 
peroxidase conjugate 




1:40000 Goat 119K4815 
Sigma-Aldrich 
Table 9: Secondary antibodies for immunofluorescence analyses 
Secondary antibody against Dilution Species Cat No./Company 
AlexaFluor 488 anti-mouse 
conjugate 
1:500 Goat 115-545-003, Jackson 
Immuno Research 
AlexaFluor 594 anti-rabbit 
conjugate 
1:500 Goat 111-475-144, Jackson 
Immuno Research 
 Software 
Table 10: Software 
Analyses Software 
Confocal images Zen 2012 (Zeiss) 
Image processing & analyses ImageJ/Fiji 
Immunoblot ImageLab 5.1 (Biorad Laboratories) 
Immunofluorescence Xcellence pro (Olympus) 
Proliferation assay Cellavista 






 Cell biology methods 
 Preparation of cardiac cells from neonatal rats and mice 
Cardiac fibroblasts were isolated from neonatal Wistar rat hearts (postnatal day 0 to 3) and 
neonatal NMRI mouse hearts (postnatal day 2 to 4) using the neonatal heart dissociation 
kit, mouse and rat (gentleMACS, Miltenyi Biotec). The isolation was performed according 
to the protocol provided by the manufacturer.  
 
First, neonatal rats and mice were sacrificed by decapitation, thoracotomy was performed 
and the complete hearts were taken out and transferred into a 10 cm cell culture dish 
containing ice-cold CBFHH buffer (rat hearts) or DPBS-buffer (mouse hearts). The following 
steps were performed on ice and under sterile conditions. To extract ventricular cells only 
the vascular pedicles and the atria were removed.  
 
The ventricles were washed twice to remove dispensable blood and afterwards cut into 
pieces of 1-2 mm3 size and washed again using CBFHH or DPBS buffer for rat and mouse 
hearts, respectively.  
Enzyme mix 1 and 2 were prepared (Table 11), enzyme mix 1 was pre-warmed at 37°C for 
5 min and afterwards added to enzyme mix 2. 







Enzyme mix 1 Enzyme mix 2 
Enzyme P Buffer X Buffer Y Enzyme A Enzyme D 
1 0.125 ml 3.125 µl 160 µl 1.25 µl 0.625 µl 5 µl 
40 5 ml 125 µl 4600 µl 50 µl 25 µl 200 µl 
60  7.5 ml 187.5 µl 6900 µl 75 µl 37.5 µl 300 µl 
The ventricular tissue was transferred to gentleMACS C tubes with tissue of 20 up to 30 
hearts per tube. Afterwards the appropriate enzyme mix was added, e.g. 2.5 ml for 20 
hearts, and the samples were incubated without agitation at 37°C for 12 min (mouse hearts) 
or 15 min (rat hearts). Then, the C tubes were attached onto the sleeve of the gentleMACS 
dissociator and the program htumor3.01 was used for the subsequent dissociation of the 




 End of digestion process and separation of cardiac fibroblasts and 
cardiomyocytes of neonatal rat hearts 
The digestion process was stopped by resuspending the cells in 7.5 ml of NCM medium. 
The suspension was strained with a mesh of stainless steel (250 µm pores) and centrifuged 
for 20 min at 60 x g at 4°C. The supernatant was discarded and the cell pellet resuspended 
in 20 ml NCM medium. To determine the number of viable cells 10 µl of the cell suspension 
was mixed with 0.4% trypan blue solution 1:1 and a Neubauer counting chamber was used 
for counting of neonatal rat cells. 
Per 15 cm cell culture dish an amount of 8 x 106 cardiac cells was seeded. To separate 
fibroblasts from cardiomyocytes NCM medium was added and the dishes were incubated 
for 45 min under humidified condition at 37°C with 5% CO2. After incubation, the NCM 
medium containing most of the cardiomyocytes was removed, the plate washed two times 
with NRCF growth medium and NRCF growth medium was added to the adherent 
fibroblasts on the dish. Medium was changed on the first day after the preparation and 
afterwards every second day. NRCF were cultured until they reached confluency at 37°C 
and 5% CO2. 
 End of digestion process and separation of cardiac fibroblasts and 
cardiomyocytes of neonatal mouse hearts 
The digestion process of neonatal mouse hearts was performed analogue to the rat hearts 
with only small modifications. Before filtering the cells, the digested mouse heart cells were 
resuspended in 10 ml NMCM medium. The cell suspension was centrifuged for 20 min at 
60 g at 4 °C. The supernatant was discarded and the pellet resuspended in 10 ml NMCM 
medium. The preplating was performed for 50 min with 15 ml cell suspension. During this 
time most of the fibroblasts adhered. The cultivation of NMCF was carried out analogue to 
the cultivation of NRCF as described above. 
 Isolation of adult mouse cardiac fibroblasts  
Adult mouse cardiac fibroblasts used for the experiments were kindly provided by Sebastian 
Pasch, Institute of Pharmacology, University Medical Centre Göttingen. The cell isolation 
was performed via Langendorff perfusion, a method in the first instance used to obtain 
cardiomyocytes, during which in addition cardiac fibroblasts can be isolated by using the 
supernatant. After centrifugation and resuspension in AMCF growth medium the fibroblasts 
were seeded on cell culture surfaces and cultivated until they reached confluency at 37°C 




 Culturing and passaging of primary cells 
Cardiac fibroblasts were kept in growth medium on cell culture surfaces and cultivated at 
37°C with 5% CO2 in a humidified incubator. To prepare the plates for passaging the 
medium was removed and the cells were washed with pre-warmed DPBS. Likewise, pre-
warmed 0.05% trypsin-EDTA was used to detach the cells from the plate. The detachment 
of the cells from the plate surface took about 3 - 5 min. The process was controlled by 
observation of the cells under the light microscope. To stop the digestion activity of trypsin, 
medium containing 10% serum was added and the dish was rinsed several times to collect 
the majority of cells. The cell suspension was centrifuged for 5 min at 300 x g and the cell 
pellet was resuspended in the respective growth media. Using the CASY cell counter 
system the cell viability and the number of cells in suspension were measured in the isotonic 
CASYton buffer. Cells were seeded in different density and on different cell culture surfaces 
depending on the experiment (see section 3.1.7). 
 Culturing and passaging of human ventricular cardiac fibroblasts 
The NHCF-V were thawed and afterwards cultured in Fibroblast growth medium-3 (FGM-3) 
under humidified conditions at 37°C with 5% CO2 as recommended by the manufacturer. 
For passaging the medium was removed, the cells were washed with DPBS and incubated 
with TrypLE Express reagent for 3-5 min at 37°C and the detachment process was 
assessed by light microscopy and stopped by adding FGM-3. The cell suspension was 
centrifuged for 5 min at 300 g, the cell pellet was resuspended in FGM-3 and the cell number 
was evaluated using the CASY cell counter. The cells were seeded on cell culture plates in 
appropriate numbers depending on the experiment. 
 Treatment with lithium chloride and tubastatin A 
To study α-tubulin acetylation and primary cilia formation, appropriate media containing 
serum and serum-free media were supplemented with either lithium chloride or tubastatin 
A. 
The lithium chloride stock solution contained 2.12 g of lithium chloride powder (Molecular 
weight: 42.39 g/mol) in 10 ml sterile water. The solution was filtered under a sterile work 
bench. Thereby a 5 M lithium chloride stock solution was generated, which was stored at 
4°C until further use. For the experiments a final concentration of 50 mM of lithium chloride 




The 3 mM tubastatin A stock solution was prepared under a sterile work bench by dissolving 
5 mg tubastatin A in 2 ml sterile water and subsequent sterile filtering of the suspension. 
Aliquots of 20 µl of this 3 mM stock solution were prepared and stored at -20°C until they 
were needed. For the experiments a final concentration of 6 µM tubastatin A was used. 
3.1.7.1 Preparation of samples for immunofluorescence analysis 
To prepare samples for immunofluorescence analysis cells were seeded into 12 well plates. 
For immunostaining on plastic approximately 30.000 cells were seeded per well. The 
samples for imaging with the confocal microscope were prepared seeding 25.000 cells per 
well on collagen-coated glass slides. For this, glass cover slips were cleaned with 70% 
Ethanol and afterwards autoclaved. The sterile cover slips were placed in a 12 well plate 
and in cold DPBS diluted rat tail collagen I (1:100) was added to each well in a laminar flow 
hood. The cover slips were incubated there for 30 min. Then, excessive collagen solution 
was removed and the cells were directly seeded on the cover slips. 
The cells were cultured for 24 h in growth medium in a humidified incubator at 37°C and 5% 
CO2. After that, cells were divided into two groups: serum-containing and no serum 
condition. For the first group only the growth medium was renewed. The cells in the second 
group were washed twice with pre-warmed serum-free medium and afterwards cultured in 
this medium for another 24 h. 
In the next step, the treatment was performed. For this, the medium was exchanged for 
either lithium chloride or tubastatin A containing medium (see chapter 4.1.7) in the presence 
or absence of serum and the incubation was carried out for 24 h at 37°C and 5% CO2. 
After the treatment was completed the medium was removed and the cells were washed 
once with DPBS. For fixation 4% PFA was added to the cells and incubated for 15 min at 
room temperature. Three washing steps with DPBS followed. The fixed cells were either 
directly used for immunofluorescence staining (3.2.1) or stored at 4°C until further use.  
3.1.7.2 Preparation of samples for protein isolation 
To prepare samples for protein isolation cells were seeded onto 6 well-plates. The cells 
were cultured in growth medium in a humidified incubator at 37°C and 5% CO2 until they 
reached 80% confluency. Thereafter, incubation was continued with serum-free medium for 
at least 24 h before the treatment was started. For this, after another change of medium, 
either lithium chloride or tubastatin A was added to the medium as described in chapter 




For cell lysis, cell scraper and lysis buffer were kept on ice until they were needed. The 
medium was removed from the plates and the cells were washed twice with DPBS. After 
complete removal of residual medium, 500 µl of ice-cold lysis-buffer was added and the 
cells were scraped off the plate. The homogenates were centrifuged for 30 min at 14.000g 
and 4°C. Samples for immunoblotting were prepared by addition of an appropriate volume 
of 4x SDS-PAGE sample buffer and subsequent incubation for 5 min at 95°C for protein 
denaturation. The remaining lysates were frozen in liquid nitrogen and stored at -80°C until 
further use. 
 Establishment of hypoxic conditions 
NRCF were seeded into 12 well and 6 well plates for immunofluorescence and protein 
isolation, respectively. The hypoxia experiments were performed with neonatal rat cardiac 
fibroblasts obtained by the isolation procedure described in sections 3.1.1 and 3.1.2. NRCF 
were cultivated and after the first passaging incubated in growth medium at 37°C in an 
incubator under humidified conditions with 20% O2 and 5% CO2 for another 24 h. To apply 
hypoxic conditions, an oxygen-controlled workstation was used. After placing the plates into 
the oxygen-controlled workstation, the growth medium was removed, the cells were washed 
with serum-free medium twice and afterwards kept in serum-free medium in the hypoxia 
chamber for 24 h at 1% O2. Afterwards the medium was changed and the cells were treated 
with lithium chloride and tubastatin A as described in section 3.1.7. The cells were kept 
under those conditions for further 24 h. Then, the cells were washed with serum-free 
medium twice and afterwards removed from the hypoxia chamber.  
To compare hypoxic and normoxic conditions, cells were treated the same way, but kept 
under normoxic conditions (20% O2). Finally, the cells were either fixed with 4% PFA for 
subsequent immunofluorescence analysis, or the protein samples were obtained, as 
described in section 3.3.1. 
 Proliferation assay 
To assess the proliferation capacity of NRCF and AMCF, the cells were trypsinised as 
described in section 3.1.5, and the number of cells determined using the CASY counting 
system. Afterwards, 24 well plates were prepared for the proliferation experiments by 
seeding 10.000 cells per well in growth medium. In total, 5 plates were prepared for each 
assay. For these experiments passage one cells only were used.  
After seeding, the cells were cultivated in growth medium for 24 h. Then one of the plates 




divided into three sections for the three different conditions: daily change of growth medium 
without further supplements as control, and change of medium with addition of either lithium 
chloride or tubastatin A. Every 24 h the cells of one plate were fixed and on the other plates 
the medium was changed and the treatment renewed. On day 4 the last 24 well plate was 
fixed. For fixation the cells were incubated with 4% PFA for 15 min. After one washing step 
with DPBS, the cells were permeabilised with 0.2% Triton X-100 for 3 min and finally 
washed with DPBS again. Subsequently, the cell nuclei were stained with DAPI (final 
concentration 1 µg/ml) for 30 min in the dark and afterwards washed three times with DPBS. 
To evaluate the proliferation rate the number of cell nuclei was measured using the 
Cellavista system.  
 Generation of engineered heart muscles (EHM) from primary neonatal 
rat cardiac cells 
Table 12: Composition of one EHM 
Components Volume  
Rat tail collagen type I (~3.5 mg/ml) 280 µl (~1 mg per EHM) 
2x DMEM 280 µl 
Matrigel 100 µl 
0.1 N NaOH App. 20 µl 
Cell suspension (2.5 x 106 cells, containing 
cardiomyocytes and cardiac fibroblasts) 
220 µl 
Total  900 µl 
The generation of EHM was carried out using a modified protocol of Zimmermann et al. 
2002. All steps were performed on ice with pre-cooled components and materials. 
Depending on the number of EHM a multiple of the volumes given in table 12 was used. 
First, collagen I and 2x DMEM containing phenol red were mixed in equal parts. Afterwards 
Matrigel was added and the pH adjusted using 0.1 N NaOH to neutralise the mixture, 
indicated by a change of colour from yellow to red. The cell suspension, containing 2.5 x 
106 cells in 220 µl EHM medium was added to the buffered ECM proteins, carefully mixed 
and casted into circular moulds. The EHM mixture was incubated at 37°C for 45 min to let 
the tissues consolidate. Then, EHM medium was added. The medium was renewed the 
following day and afterwards every second day. EHM were then transferred on phasic 
stretchers after 5 days and stretched at a frequency of 1 Hz for 24 h. Phasic stretching was 




 Generation of engineered connective tissue (ECT) from primary 
neonatal rat cardiac fibroblasts  
Table 13: Composition of one ECT 
Components  Volume  
Rat tail collagen type I (~3.5 mg/ml) 400 µl (~1.4 mg per ECT) 
2x DMEM 400 µl 
0.1 N NaOH App. 50µl  
Cell suspension (1.5 x 106 cells/ECT) App. 50µl (depending on volume of NaOH) 
Total  900µl 
To prepare ECT, NRCF were cultured in NRCF medium containing 10% serum for 24 h. 
The cells were digested and transferred into a reaction tube. After cells were counted using 
the CASY Cell Counter, the cell suspension was centrifuged, the supernatant discarded 
and the pellet resuspended in appropriate volume of growth medium (see section 3.1.5). 
The following steps of ECT preparation were performed on ice. First, equal volumes of 
collagen and 2x DMEM were mixed and NaOH was added to neutralise pH by titration. 
About 1.5 million cells were added per ECT in an appropriate volume of medium, resulting 
in 900 µl of mixture per ECT. The mixture was pipetted into circular casting moulds and 
incubated for consolidation for 45 min at 37°C. Then 7ml of 10% NRCF medium was added 
to each mould. The medium was changed after 24 h and then every second day. After five 
days the medium was changed to serum free medium and then cultured for another 48 
hours. For lithium chloride treatment of ECT after 24 h lithium chloride was added to the 
serum free medium in a final concentration of 50 mM. 
 Histological methods 
 Fluorescence staining of cells in cell culture plates 
The fixed cells in 12 well plates (see section 3.1.7.1) were permeabilised for 3 min with 
0.2% Triton X-100. After three washing steps with DPBS, Roti-Block was added to the cells 
for 1 h to block unspecific binding of antibodies. Then, the cells were washed once and 
incubated with the diluted primary antibodies overnight at 4°C on a shaking plate. The 
dilutions of the antibodies are given in table 7. The next day, the cells were washed three 
times with DPBS and the secondary antibody together with 1 µg/ml DAPI and 0.5 µg/ml 
TRITC-Phalloidin in DPBS were incubated for 1 h at room temperature in the dark.  
Finally, the cells were washed 3 times with DPBS and afterwards stored at 4°C in the dark 




 Fluorescence staining of cells on glass cover slips 
For confocal microscopy, the cells were cultured, treated and fixed on collagen-coated glass 
cover slips as described in section 3.1.7. Permeabilization and blocking was carried out 
simultaneously with blocking and permeabilisation buffer containing 10% fetal calf serum 
and 0.2% Triton X-100 in DPBS (see table 6) for 45 min. The primary antibodies were diluted 
in the same buffer as used for permeabilisation and blocking and incubated with the 
samples overnight. The dilutions of the antibodies are given in table 7. After three washing 
steps with blocking buffer, the secondary antibodies (see table 9) in blocking buffer were 
added and incubation was carried out in the dark for 4 hours. In the last 30 min 0.5 µg/ml 
TRITC-Phalloidin and 1 µg/ml DAPI were added. Next, the cells were washed with DPBS 
three times and the cover slips were mounted with Fluoromount on microscope slides and 
sealed with nail polish on the following day. The samples were stored at room temperature 
in the dark until further usage.  
 Preparation of vibratome sections of engineered tissue 
EHM and ECT were fixed in 4% PFA in DPBS overnight. After washing with DPBS, the 
engineered tissue samples were embedded in 2% agarose dissolved in TAE buffer in 6 well 
plates. The embedded samples were kept at 4°C overnight for complete hardening. Cuboids 
of agarose containing the EHM or ECT were cut out and fixed on the vibratome surrounded 
by cold DPBS. Slices of 100 µm thickness were cut, transferred into a 6 well plate filled with 
DPBS and stored at 4°C until used for immunostaining. 
 Fluorescence staining of engineered tissue 
The vibratome sections of engineered tissue were using a blocking and permeabilisation 
buffer containing Roti-Block and 0.2% Triton X-100 in aqua dest. (see table 6) at 4°C for 1 
hour. The primary antibodies were added to the described buffer and the sections were 
incubated at 4°C overnight whilst shaking. The next day three washing steps with DPBS 
were performed and the secondary antibodies were incubated overnight in the dark whilst 
shaking. After three washing steps with DPBS the sections were incubated with 0.5 µg/ml 
TRITC-Phalloidin and 1 µg/ml DAPI for 45 min at room temperature in the dark. The agarose 
was removed and the tissue sections were mounted on glass slides using Fluoromount and 
cover slips to envelope the samples. Finally, the cover slips were sealed with nail polish on 
the following day. The glass slides were stored in the dark at room temperature until used 




 Protein biochemical methods 
 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) 
To separate proteins according to their size, SDS-PAGE was performed, using a 5% 
stacking gel and a resolving gel containing a 10% acrylamide/bisacrylamide concentration, 
see table 14. 
Table 14: Components of stacking and resolving gel for SDS-PAGE 
Reagent 5% stacking gel 10% resolving gel 
ddH2O 2.8 ml 1.9 ml 
1.0 M Tris/HCl, pH 6.8 0.38 ml - 
1.5 M Tris/HCl, pH 8.8 - 1.3 ml 
Acrylamide/bisacrylamide 
mix (29%/1%) 
1.3 ml 1.7 ml 
10% SDS 0.03 ml 0.05 ml 
10% APS 0.03 ml 0.05 ml 
TEMED 0.003 ml 0.003 ml 
Total volume 3 ml 5 ml 
Protein samples, prepared as described in section 3.1.7.2, were loaded onto the prepared 
gels and separated with constant 200 Volt in 1x SDS running buffer for approximately 45 
min until the bromophenol blue of the sample buffer reached the end of the gel. 
 Immunoblotting 
After the proteins had been separated by SDS-PAGE, they were transferred onto a 
nitrocellulose membrane. For this the gel and the membrane were layered between filter 
paper and soaked in 4°C cold immunoblotting buffer. 100 Volt were applied for 1 h, while 
the gel and membrane were kept in the cold immunoblotting buffer. Thereby the proteins 
were successfully transferred onto the membrane, which could be shown by Ponceau-S 
staining afterwards. After incubation in Ponceau-S solution for 5 min, the membrane was 
washed three times with distilled water until only the single bands stayed visible. Images of 
the staining were taken and the membrane was cut into strips for detection of the respective 
proteins. The remaining Ponceau-S staining was washed off using TBST. The cut 
membrane was incubated in 1x Roti-Block for 1 h at room temperature whilst shaking to 




at 4°C with the respective primary antibody diluted in TBST on a shaking plate. The used 
antibody concentrations are given in table 7. The next day, the membranes were washed 
at room temperature three times with TBST, each washing step was carried out for 10 min, 
and afterwards the horseradish peroxidase (HRP)-conjugated secondary antibodies in 
TBST were applied to the membranes. The used antibody concentrations are given in table 
8. The incubation was performed at room temperature whilst continuously shaking. The 
membrane strips were then washed three times for 10 min each with TBST and afterwards 
the HRP activity was detected with a chemoluminescence detection system using an 
enhanced chemoluminescence substrate (Lumi-LightPLUS). The following quantitative 
analysis was carried out with the help of ImageLab 5.1 analysis software. 
 Microscopy 
Imaging was performed either using an inverted microscope for epifluorescence microscopy 
(Olympus IX81) or a confocal microscope (Zeiss, LSM 170). 
 Epifluorescence microscopy 
For engineered tissue and for taking pictures for primary cilia measurement the inverted 
fluorescence microscope was used. Microscopy was carried out in the dark.  
The following filters and objectives were used:  
• filter DAPI BP 403/12 Olympus 
• filter EGFP BP 470/20 Olympus 
• filter Texas Red BP 572/23 Olympus 
• objective 20x LUCPLFLN20xPH/ 0.45 Olympus 
• objective 40x LUCPLFLN40xPH/ 0.60 Olympus 
• objective 60x PlanApo N60x/ 1.42 oil Olympus 
 Confocal microscopy 
For higher resolution images, z-stack-analysis and 3D reconstruction confocal laser 
scanning microscopy was performed. 
The following objectives were used:  
• objective 10x:  EC Plan-Neofluar/ 0.3 (Zeiss LSM 710) 
• objective 20x:  EC Plan-Neofluar/ 0.5 (Zeiss LSM 710) 
• objective 63x:  Plan-Apochromat/ 1.4 oil (Zeiss LSM 710) 




Laser intensity and gain were adjusted depending on the signal.  
 Quantitative and statistical analysis 
 Measurement of primary cilia length and percentage of cells with cilia 
For measurement of the length of primary cilia of cardiac fibroblasts FIJI/ImageJ was used 
to analyse immunostainings. The pictures for length measurement were taken with an 
inverted fluorescence microscope (Olympus IX81) at a magnification of 320x. Besides 
acetylated α-tubulin the nuclei were imaged for better orientation. A stack of all images was 
prepared. 
The information of the pixel size was manually added in the programme and the cilia were 
measured using the tool “free hand line”. The data of every stack was transferred to Prism 
to measure means and standard error and for graphical presentation. 
In addition to the cilia length, the fraction of cells carrying primary cilia was determined. For 
this, images of acetylated α-tubulin and DAPI staining were taken with a magnification of 
200x. Each 12 well plate contained 4 wells of each condition (control/TubA/LiCl) and per 
well 10 images were taken. With the help of the image stacks and FIJI/ImageJ, the total cell 
number was determined as well as the percentage of cells carrying primary cilia. 
 
Figure 5: Measurement of primary cilia length. Immunofluorescence staining of acetylated tubulin 
of NRCF after treatment with lithium chloride under serum-starved conditions. The image was taken 
with an inverted fluorescence microscope at a magnification of 320x. The primary cilium length (red 
line) was measured with the “free hand line” tool of FIJI/ImageJ. 
 








 Primary cilia in cardiac fibroblasts 
 Primary cilia are present in cardiac fibroblasts in 2 D culture 
Since it was unknown whether cardiac fibroblasts possess primary cilia, cultured neonatal 
rat cardiac fibroblasts (NRCF) were used for immunofluorescence analysis. Acetylated α-
tubulin and γ-tubulin were detected with specific antibodies and the nuclei were stained with 
DAPI. Confocal microscopy revealed that on top of NRCF nuclei, primary cilia could be 
detected characterised by their main structural shaft component acetylated α-tubulin and 
the main basal body component γ-tubulin (Fig. 6). 
 
Figure 6: Confocal microscopy of a primary cilium in a serum-starved NRCF. Serum-starved 
2D cardiac fibroblast cultures derived from neonatal rats (NRCF) were used for immunofluorescence 
analysis. Acetylated α-tubulin (green) and γ-tubulin (red) were detected with specific antibodies, the 
nuclei were stained with DAPI (blue), and confocal imaging was performed. Shown are the single 
channels in grayscale and the merge in color. The arrow indicates a primary cilium. A magnification 





 Primary cilia are present in cardiac fibroblasts of different species 
To investigate if primary cilia are present in cardiac fibroblasts of different species, 
acetylated α-tubulin was detected by immunofluorescence in neonatal and adult mouse 
cardiac fibroblasts (NMCF and AMCF), in human ventricular cardiac fibroblasts (HVCF) and 
in addition for comparison in NRCF. For better orientation nuclei were stained with DAPI. In 
all investigated 2D cardiac fibroblasts cultures primary cilia were present on top or directly 
next to nuclei.  
Figure 7: Fluorescence microscopy of primary cilia in serum-starved NRCF, NMCF, AMCF and 
HVCF. Serum-starved 2D cardiac fibroblast cultures derived from neonatal rats (NRCF), neonatal 
mice (NMCF), adult mice (AMCF) and humans (HVCF) were used for immunofluorescence analysis. 
Acetylated α-tubulin (grayscale) was detected with a specific antibody, the nuclei were stained with 
DAPI (blue) and fluorescence imaging was performed. Shown are the overlays. A magnification of 
320x was used. 
 Primary cilia are present in engineered connective tissue 
In the next step, the presence of primary cilia in 3D cardiac fibroblast cultures was 
examined. For this purpose, engineered connective tissues (ECT), composed of NRCF and 
collagen I, were prepared. After sectioning and staining of acetylated α-tubulin, confocal 
imaging was performed. In addition, F-actin was detected with TRITC-phalloidin to 
determine the cell borders. As shown in figure 8A, primary cilia can be found under control 
conditions, however, not all cells seem to possess these structures (left images vs. right 
images). The treatment of cells with lithium chloride had been demonstrated to influence 
primary cilia length (Nakakura et al. 2015). Therefore, ECT were treated in parallel for the 
last 24 h with 50 mM lithium chloride and primary cilia were detected. As shown in figure 
8B, the length of primary cilia was increased and interestingly split primary cilia or pairs of 





Figure 8: Confocal microscopy of primary cilia in engineered connective tissues. Engineered 
connective tissues (ECT) were generated from neonatal rat cardiac fibroblasts and collagen I. During 
the last 2 culture days, the ECT were either serum-starved (A) or serum-starved for 24 h and 
afterwards treated with 50 mM lithium chloride under serum-starved conditions for further 24 h (B). 
Vibratome sections of 100 µm thickness were prepared and acetylated α-tubulin (green) was 
detected with a specific antibody. In addition, F-actin was stained with TRITC-Phalloidin (red). Shown 
are the single channels and the merges of two examples each. Arrow indicates a primary cilium. A 
magnification of 630x was used. The white scale bars represent 20 µm. The rectangles mark the 






 Primary cilia are present in engineered heart muscles 
The data so far shows that primary cilia can be detected in homogenous 2D and 3D cultures 
of cardiac fibroblasts. This raised the question whether primary cilia are also present in 
contractile heart muscle. The attempt to detect primary cilia in native myocardium, however, 
failed due to several reasons. First, in the adult myocardium cardiac fibroblasts are difficult 
to identify because of the lack of specific cell markers. Second, staining of myocardial tissue 
with an antibody against acetylated α-tubulin led to strong signals in neuronal cells. These 
cells stabilise their axons by acetylated α-tubulin. By sectioning of heart tissue, the 
meandering axons were occasionally cut and thus primary cilia-shaped artefacts were 
produced (data not shown). Therefore, engineered heart muscles (EHM) were used in the 
following to analyse the presence of primary cilia in a heterogenous and contractile 
environment. EHM were prepared of all cardiac cells isolated from neonatal rat hearts. The 
maturation of cardiomyocytes and syncytium formation was induced by phasic stretch. After 
19 days in culture the EHM showed coherent spontaneous beating. To study the presence 
of primary cilia in EHM, the tissues were sectioned and immunofluorescence analysis of 
acetylated α-tubulin was performed. In addition, F-actin was stained to identify 
cardiomyocytes by their sarcomeric actin pattern as well as nuclei were detected to verify 
the presence of primary cilia due to their perinuclear localization. In figure 9, fluorescence 
images are presented of a less densely packed area in an EHM. The staining of acetylated 
α-tubulin suggested that in EHM ciliated cells are present. Especially cells without prominent 





Figure 9: Fluorescence microscopy of primary cilia in engineered heart muscle. Engineered 
heart muscle (EHM) were generated from neonatal rat heart cells and collagen I. Shown is an 
immunostaining of acetylated α-tubulin (green) of a 100 µm thick vibratome section. F-actin was 
stained with TRITC-Phalloidin (red) and the nuclei with DAPI (blue). Imaging was performed by 
fluorescence microscopy. Single channels are shown in grayscale and the merge in color. A 
magnification of 320x was used. The white scale bar represents 50µm. 
 
To further validate this finding, higher magnification images were taken. Again, cells with 





Figure 10: Fluorescence microscopy of cardiomyocytes (CM) in engineered heart muscle 
detected by F-actin staining. Engineered heart muscle (EHM) were generated from neonatal rat 
heart cells and collagen I. Shown is an immunostaining of acetylated α-tubulin (green) of a 100 µm 
thick vibratome section. F-actin was stained with TRITC-Phalloidin (red) and the nuclei with DAPI 
(blue). Imaging was performed by fluorescence microscopy. Single channels are shown in grayscale 
and the merge in color. The cardiomyocyte was identified by its actin striation and is labelled with 
CM. A magnification of 600x was used. The white scale bar represents 20 µm.  
4.1.4.1 Primary cilia could not be found on cardiomyocytes in EHM 
To more exactly characterise ciliated cardiac cells in EHM, immunofluorescence analysis 
of acetylated α-tubulin and specific cell markers was performed. First, cardiomyocytes were 
detected in addition to their unique actin pattern by caveolin-3 expression. This caveolin 
isoform is exclusively expressed in striated muscle cells. Two representative examples of 
striated and caveolin-3 positive cardiomyocytes in EHM are shown in figure 11. Although, 
acetylated α-tubulin could be detected in these cells, no primary cilia were present. This 
data suggests that cardiomyocytes in EHM, showing a certain degree of maturity, are not 
carrying primary cilia. Whether immature cardiomyocytes, with less organized sarcomeres, 





Figure 11: Fluorescence microscopy of cardiomyocytes (CM) in engineered heart muscle 
detected by F-actin and caveolin-3 staining. Engineered heart muscle (EHM) were generated 
from neonatal rat heart cells and collagen I. Shown are immunostainings of acetylated α-tubulin 
(green) and caveolin-3 (Cav-3, yellow) of two 100 µm thick vibratome sections. F-actin was stained 
with TRITC-Phalloidin (red) and the nuclei with DAPI (blue). Imaging was performed by fluorescence 
microscopy. Single channels are shown in grayscale and the merges in color. The cardiomyocytes 
were identified by their actin striation and Cav-3 expression and are labelled with CM. A magnification 
of 960x was used.  
4.1.4.2 Primary cilia could be found on endothelial tube-like structures 
As reported by Naito and colleagues (Naito et al. 2006) in rat engineered heart tissues tube-
like structures develop, which are composed of endothelial cells. Endothelial cells had been 
described to carry primary cilia on their luminal side (Nauli et al. 2008). To test whether 
endothelial tubes could be detected in the used EHM, and more importantly whether 
endothelial cells possess primary cilia in EHM, the endothelial marker CD31 was stained 
together with acetylated α-tubulin, F-actin and DAPI. CD31, also known as platelet 
endothelial cell adhesion molecule-1 (PECAM-1), is a transmembrane protein located in the 




By CD31 staining tube-like structures could be detected in EHM. These tubes were built of 
cells with elongated nuclei and were showing a punctured CD31 localisation, probably 
reflecting cell-cell junctions (Fig. 12A). Branched tubes could also be detected (Fig. 12B). 
The tube-forming, CD31-positive endothelial cells, were in addition positive for acetylated 
α-tubulin. Occasionally primary cilia could be detected on the outside of these tubes (Fig. 
12B). Whether these are primary cilia of endothelial cells with a missing cell polarity or these 
primary cilia belong to the tube stabilizing pericytes, has to be elucidated further. 
 
Figure 12: Fluorescence microscopy of endothelial cells (EC) in engineered heart muscle 
detected by CD31 staining. Engineered heart muscle (EHM) was generated from neonatal rat heart 
cells and collagen I. Shown are immunostainings of acetylated α-tubulin (green) and CD31 
(grayscale) of a 100 µm thick vibratome section. F-actin was stained with TRITC-Phalloidin (red) and 
the nuclei with DAPI (blue). Imaging was performed by fluorescence microscopy. Single channels 
are shown in grayscale and the merges in color. The endothelial cells were identified by their CD31 
expression and are labelled with EC. The arrow indicates a primary cilium. Magnification of 600x (A) 




Next, caveolin-1 was stained in addition to acetylated α-tubulin, actin and DAPI. Caveolin-
1 is the main structural caveolin isoform in cells others than striated muscle cells. The 
strongest caveolin-1 expression could be detected in elongated cells, which are most likely 
due to their elongated nuclei endothelial cells. Similar as shown for CD31-positive cells, 
these cells were positive for acetylated α-tubulin and carried in some cases on their outside 
primary cilia (Fig. 13). 
 
Figure 13: Fluorescence microscopy of endothelial cells (EC) in engineered heart muscle 
detected by caveolin-1 staining. Engineered heart muscle (EHM) were generated from neonatal 
rat heart cells and collagen I. Shown are immunostaining of acetylated α-tubulin (green) and 
caveolin-1 (Cav-1, yellow) of a 100 µm thick vibratome section. F-actin was stained with TRITC-
Phalloidin (red) and the nuclei with DAPI (blue). Imaging was performed by fluorescence microscopy. 
Single channels are shown in grayscale and the merges in color. Endothelial-like cells were strongly 
positive for caveolin-1 and are labelled with EC. The arrow indicates a primary cilium. A magnification 
of 960x was used.  
4.1.4.3 Primary cilia could be found on cardiac fibroblasts in EHM 
In less densely packed regions of EHM, where no or only few cardiomyocytes could be 
detected, most cells carried primary cilia (Fig. 14A). These highly abundant cells were only 
faintly positive for F-actin and acetylated α-tubulin, and negative for CD31 (Fig. 14B). In 
addition, they were negative for caveolin-3 (not shown). The cells possessed ellipsoid nuclei 
and a branched cortical actin cytoskeleton. Taken together, these findings strongly argue 





Figure 14: Fluorescence microscopy of cardiac fibroblasts (CF) in engineered heart muscle. 
Engineered heart muscle (EHM) were generated from neonatal rat heart cells and collagen I. Shown 
are immunostainings of acetylated α-tubulin (green) of two 100 µm thick vibratome section. F-actin 
was stained with TRITC-Phalloidin (red) and the nuclei with DAPI (blue). In B) CD31 was stained in 
addition. Imaging was performed by fluorescence microscopy. Single channels are shown in 
grayscale and the merges in color. The cardiac fibroblasts are labelled with CF. The arrows indicate 
primary cilia. The images were taken with magnifications of 200x (A), 600x (B) and 960x (C). The 




4.1.4.4 Primary cilia are present in more densely packed muscle strands 
Muscle strands responsible for the coherent beating of EHM are not uniformly distributed in 
engineered tissues. Since so far all ciliated cells were detected in less densely packed 
regions of EHM, next, areas containing muscle strands were analysed. Therefore, confocal 
z-stack analysis was performed. In figure 15 a 3D reconstruction of such a muscle strand 
is depicted. Interestingly, long thin fibre-like structures are connected to the muscle fibre, 
which are strongly positive for acetylated α-tubulin. Due their shape, these fibres are likely 
to be axons of neuronal cells in EHM, which had, however, not been described so far in 
engineered heart tissue.  
 
Figure 15: Confocal microscopy of densely packed muscle strands in engineered connective 
tissue. Engineered heart muscle (EHM) were generated from neonatal rat heart cells and collagen 
I. Shown is a 3D reconstruction of a confocal z-stack of immunostained acetylated α-tubulin (green) 
and CD31 (red, only shown in the merge) of a 100 µm thick vibratome section. F-actin was stained 
with TRITC-Phalloidin (grayscale) and the nuclei with DAPI (blue). Single channels are shown in 
grayscale and the merge in color. The 3D-reconstruction was generated of 44 z-slices representing 
a total z-depth of 14.5 µm. 
By using higher magnifications, single cells could be located on the surface of muscle 
stands in EHM carrying primary cilia (Fig. 19). As these cells do not possess a very 




However, future studies are needed to further discriminate between the different cells types 
in these complexly composed engineered tissues. 
 
Figure 16: Confocal microscopy of primary cilia in densely packed muscle strands in 
engineered connective tissue. Engineered heart muscle (EHM) were generated from neonatal rat 
heart cells and collagen I. Shown are two slices of a z-stack (upper two rows) of immunostained 
acetylated α-tubulin (green) of a 100 µm thick vibratome section. F-actin was stained with TRITC-
Phalloidin (grayscale) and the nuclei with DAPI (blue). Merges are shown of acetylated α-tubulin and 
DAPI, of actin and DAPI as well as of all tree channels. The arrows indicate primary cilia. In the 
bottom row a magnification of single z-stack images of the acetylated α-tubulin stain is shown. The 






 Neither serum-starvation nor treatment with tubastatin A and lithium 
chloride lead to a change of number of primary cilia 
After the presence of primary cilia in cardiac fibroblasts in 2D and 3D cultures had been 
proven, the regulation of primary cilia by serum, tubastatin A and lithium chloride was 
assessed. First, the fraction of ciliated NRCF in 2D cultures treated with these substances 
was quantified in immunofluorescence images (Fig. 19A). Although it has been shown that 
10% serum induces the proliferation rate of NRCF (Jatho et al. 2015), and thus less primary 
cilia could be expected (Plotnikova et al. 2009), no difference in the fraction of ciliated NRCF 
were found. In the absence of serum as well as in the presence of 10% serum around 60% 
of cells were ciliated. This was by trend diminished, when the cells were treated with 6 µM 
tubastatin A for 24 h (Fig. 17B). Tubastatin A is supposedly a specific inhibitor for HDAC6, 
the main α-tubulin deacetylase. By immunofluorescence analysis the effect of HDAC6 
inhibition became apparent as an increase of acetylated microtubules spreading throughout 
the whole cell, instead of being confined to the perinuclear region. This effect of tubastatin 
A was not different between starved and serum-treated NRCF (Fig. 17A). In contrast to 
tubastatin A, application of 50 mM lithium chloride, which was demonstrated to mobilises 
the α-tubulin N-acetyltransferase 1 (Nakakura et al. 2015) had no effect on the number of 







Figure 17: Fluorescence microscopy and quantification of primary cilia in NRCF after 
tubastatin A and LiCl treatment. 2D cardiac fibroblast cultures derived from neonatal rats (NRCF) 
were cultured for 24 h in the presence or absence of 10% serum.Afterwards, 6 µM tubastatin A 
(TubA) or 50 mM LiCl were added to both conditions as indicated and the cells were cultured for 
further 24 h. Acetylated α-tubulin (grayscale) was detected with a specific antibody, and fluorescence 
imaging was performed. A) Shown are representative images with a magnification of 200x. The white 
scale bars represent 100µm. B) The number of ciliated cells was counted and is given as fraction of 
all cells. Shown are the means±SEM of three independent experiments (n=3). In each experiment a 





 Primary cilia length increases under serum-starvation and after 
treatment with lithium chloride 
Next, the effect of serum, tubastatin A and lithium chloride on the length of primary cilia was 
analysed. As already demonstrated for the ECT model, lithium chloride treatment could 
elongate primary cilia in NRCF (see Fig. 8). As shown in the confocal microscopy images 
in figure 18, this seemed to be also the case in 2D NRCF cultures, when the cells were 
serum-starved beforehand. In contrast, tubastatin A showed no obvious effect on primary 
cilia length. 
 
Figure 18: Confocal microscopy of primary cilia in NRCF after tubastatin A and LiCl treatment. 
2D cardiac fibroblast cultures derived from neonatal rats (NRCF) were cultured for 24 h in the 
absence of serum and afterwards 6 µM tubastatin A (TubA) or 50 mM LiCl in serum-free medium 
was added. The cells were cultured for further 24 h. Acetylated α-tubulin (green) was detected with 
a specific antibody, F-actin was stained with TRITC-Phalloidin (red) and the nuclei with DAPI (blue). 
Confocal imaging was performed. Single channels are shown in grayscale and the merges in color. 
The arrows indicate primary cilia. A magnification of 630x was used. 
For quantification of primary cilia lengths, fluorescence microscopy images were used and 
the lengths were determined with the freehand line tool of Image J. The withdrawal of serum 




mean primary cilium length in the presence of serum was 1.6 µm and by withdrawal of 
serum it increased to 2.72 µm. Under both conditions the application of 50 mM lithium 
chloride led to an elongation of primary cilia, resulting in lengths of 2.4 µm and 4.6 µm in 
the presence and absence of serum, respectively. In contrast, no effect could be detected 
in response to tubastatin A.  
 
Figure 19: Quantification of primary cilia length in NRCF after tubastatin A and LiCl treatment. 
2D cardiac fibroblast cultures derived from neonatal rats (NRCF) were cultured for 24 h in the 
presence or absence of serum and afterwards 6 µM tubastatin A (TubA) or 50 mM LiCl in serum-
containing or serum-free medium was added. The cells were cultured for further 24 h. Acetylated α-
tubulin (green) was detected with a specific antibody. Fluorescence imaging was performed and the 
length of primary cilia was measured with the freehand line of Image J. Given are the means±SEM 
of three independent experiments (n=3). In each experiment a minimum of 23 cells per condition 
were analysed, *p<0.05 assessed by one-way ANOVA. 
 Primary cilia regulation in hypoxia 
During pathological processes such as myocardial infarction cardiac fibroblasts are 
exposed to hypoxia. To elucidate how hypoxia influences α-tubulin acetylation and 
importantly primary cilia formation in cardiac fibroblasts, NRCF were kept in culture at 1% 
O2 and 20 % O2, representing hypoxia and normoxia, in parallel. In addition, the cells were 
again treated with tubastatin A and lithium chloride to see, if hypoxia interferes with these 
substances. By immunofluorescence analysis of acetylated α-tubulin, no obvious 
differences in cell morphology could be detected with respect to oxygen levels. Under 




mainly detected around the nucleus, after tubastatin A treatment acetylated microtubules 
where evenly distributed in the cells (Fig. 20). 
 
Figure 20: Fluorescence microscopy of primary cilia in serum-starved NRCF under hypoxic 
and normoxic condition with additional TubA or LiCl treatment. 2D cardiac fibroblast cultures 
derived from neonatal rats (NRCF) were cultured for 48 h in the absence of serum either under 
normoxic (20% O2) or hypoxic (1% O2) conditions. In the last 24 h 6 µM tubastatin A (TubA) or 50 
mM LiCl was added. Acetylated α-tubulin (grayscale) was detected with a specific antibody, the 
nuclei were stained with DAPI (blue) and fluorescence imaging was performed. Shown are the 
overlays. A magnification of 200x was used. 
 Hypoxia leads to no change in number of primary cilia in cardiac 
fibroblasts under control condition 
The fraction of ciliated cells was measured after immunofluorescent staining of acetylated 
α-tubulin, comparing NRCF cultured with 20% O2 and 1% O2 under control condition and 
after treatment with tubastatin A and lithium chloride. Under normoxic conditions, tubastatin 
A treatment reduced the fraction of ciliated cells as described above. In this set of 
experiments, the decline was significant due to the lower variances of the data sets. And 
again lithium chloride showed no effect on the number of ciliated cells. In hypoxia compared 
to normoxia, a further decline after tubastatin A treatment was observed, whereas in the 






Figure 21: Quantification of ciliated, serum-starved NRCF under hypoxic and normoxic 
condition with additional TubA or LiCl treatment. 2D cardiac fibroblast cultures derived from 
neonatal rats (NRCF) were cultured for 48 h in the absence of serum either under normoxic (20% 
O2) or hypoxic (1% O2) conditions. In the last 24 h 5 µg/mL tubastatin A (TubA) or 50 mM LiCl was 
added. Acetylated α-tubulin was detected with a specific antibody and fluorescence imaging was 
performed. The number of ciliated cells was counted and is given as fraction of all cells. Shown are 
the means±SEM of three independent experiments (n=3). In each experiment a minimum of 414 
cells per condition were analysed, *p<0.05.  
 Hypoxia increases primary cilia length in cardiac fibroblasts 
Besides the fraction of ciliated cells, the length of cilia in normoxia and hypoxia was 
compared. It has been suggested, that hypoxia-inducible factor 1-alpha (HIF1-α) 
contributes to primary cilia length in renal epithelial cells upon renal injury (Verghese et al. 
2011). The analysis of primary cilia length under normoxic and hypoxic conditions showed 
that hypoxia significantly increases primary cilia length in NRCF, under control conditions. 
Application of lithium chloride increased primary cilia length in normoxia and hypoxia. 
Tubastatin A, in contrast, had no effect on cilia length in normoxia and blunted the hypoxia-





Figure 22: Quantification of primary cilia length in serum-starved NRCF under hypoxic and 
normoxic condition with additional TubA or LiCl treatment. 2D cardiac fibroblast cultures derived 
from neonatal rats (NRCF) were cultured for 48 h in the absence of serum either under normoxic 
(20% O2) or hypoxic (1% O2) conditions. In the last 24 h 6 µM tubastatin A (TubA) or 50 mM LiCl was 
added. Acetylated α-tubulin was detected with a specific antibody and fluorescence imaging was 
performed. The length of primary cilia were measured with the free hand tool of Image J. Given are 
the means±SEM of three independent experiments (n=3). In each experiment a minimum of 39 cells 
per condition were analysed, *p<0.05 assessed by one-way ANOVA. 
 Tubastatin A and lithium chloride increase α-tubulin acetylation under 
normoxic and hypoxic condition 
To assess whether the induction of hypoxia in NRCF was successful and if hypoxia 
influences α-tubulin acetylation, immunoblot analysis for HIF1-α and acetylated α-tubulin 
was carried out. In addition, total α-tubulin, β-actin and vinculin were analysed as loading 
controls. As shown in figure 23, in lysates of cells, which had been exposed to hypoxia 
HIF1-α was stabilized proving the lowered oxygen levels during culture. In addition, a strong 
increase in acetylated α-tubulin was detected after tubastatin A treatment independent of 
the oxygen levels showing that HDAC6 inhibition was successful. In the same samples, the 
total α-tubulin signal was reduced compared to control. To ensure that this was not due to 
unequal total protein loading, β-actin and vinculin were analysed in addition. Both showed 




cells treated with lithium chloride appeared to be slightly higher as in the corresponding 
controls. 
 
Figure 23: Immunoblot of α-tubulin acetylation in NRCF under normoxic and hypoxic 
conditions with additional tubastatin A or LiCl treatment. 2D cardiac fibroblast cultures derived 
from neonatal rats (NRCF) were cultured for 48 h in the absence of serum either under normoxic 
(20% O2) or hypoxic (1% O2) conditions. In the last 24 h 6 µM tubastatin A (TubA) or 50 mM LiCl was 
added. By immunoblot analysis acetylated α-tubulin, total α-tubulin, HIF-1α, β-actin and vinculin were 
detected with specific antibodies in cell lysates containing equal protein amounts. Shown are 
representative immunoblots. 
 Comparison of α-tubulin acetylation and primary cilia regulation in 
cardiac fibroblasts from different species 
The data presented so far, demonstrate the effects of tubastatin A and lithium chloride on 
primary cilia number and length as well as on α-tubulin acetylation in NRCF. Analysis of 
cardiac fibroblast from other species suggested that the presence of primary cilia on cardiac 
fibroblasts is conserved over species and developmental stages (see Fig. 7). To analyse 
this in more detail, adult mouse cardiac fibroblasts (AMCF) were compared with NRCF first 
with respect to their levels of acetylated α-tubulin by immunoblot. In AMCF the ratio of 





Figure 24: Comparison of α-tubulin acetylation in NRCF and AMCF by immunoblot analysis. 
Serum-starved 2D cardiac fibroblast cultures derived from neonatal rats (NRCF) and adult mice 
(AMCF) were used for immunoblot analysis. Acetylated α-tubulin and total α-tubulin were detected 
with specific antibodies in cell lysates containing equal protein amounts. Shown are representative 
immunoblots (left) and the analysis of acetylated α-tubulin normalized by α-tubulin. The values are 
given as means±SEM relative to NRCF, n=3, significance was tested vs. NRCF assessed by 
unpaired t-test. 
 Tubastatin A and lithium chloride increase α-tubulin acetylation 
In the next step, the effects of tubastatin A and lithium chloride on α-tubulin acetylation was 
compared in NRCF and AMCF by immunoblot analysis. As already demonstrated in figure 
17A, tubastatin A treatment led to a strong increase in acetylated α-tubulin in NRCF. By 
quantification a 22-fold and 12-fold increase was found for NRCF and AMCF, respectively. 
The treatment with lithium chloride increased α-tubulin acetylation only moderately and to 
the same extent in both cell types. In NRCF the increase was 2.2-fold and in AMCF 2.0-fold 






Figure 25: Quantification of α-tubulin acetylation by immunoblot analysis in NRCF and AMCF 
treated with tubastatin A and LiCl. 2D cardiac fibroblast cultures derived from neonatal rats (NRCF, 
shown in A) and adult mice (AMCF, shown in B) were cultured for 24 h in the absence of serum and 
afterwards 6 µM tubastatin A (TubA) or 50 mM LiCl in serum-free medium was added as indicated. 
The cells were cultured for further 24 h. By immunoblot analysis acetylated α-tubulin, total α-tubulin 
and β-actin were detected with specific antibodies in cell lysates containing equal protein amounts. 
Shown are representative immunoblots (left) and the analysis of acetylated α-tubulin normalized by 
α-tubulin. The values are given as means±SEM relative to untreated control, n=3, *p<0.05 vs. control 
assessed by one-way ANOVA. 
Next, the frequency of ciliated AMCF and the length of primary cilia were analysed under 
basal conditions and after tubastatin A and lithium chloride treatment. Although the basal 
levels of acetylated α-tubulin were higher in AMCF compared to NRCF, the fraction of 
ciliated cells were lower. Only around 30% of AMCF were found to be ciliated under control 
condition (Fig. 26A). In contrast, the percentages of NRCF ranged from 50% to 60% (see 




compared to NRCF. Under control condition a mean length in AMCF of 0.6 µm was found, 
whereas in NRCF the mean length in the absence of serum ranged between 1.7 µm and 
2.7 µm (see Fig. 19 and Fig. 26). Similar as in NRCF, treatment of AMCF with tubastatin A 
resulted in a frequency reduction of ciliated cells and had no influence on primary cilia 
length. The decline in the number of ciliated cells was more pronounced in AMCF than in 
NRCF, although the relative effect of tubastatin A on the increase in acetylated α-tubulin 
was lower (see Fig. 25). Lithium chloride treatment had no effect on the number of ciliated 
AMCF as previously shown for NRCF and it increased the mean primary cilia length to 1.2 
µm. The relative effect of lithium chloride on primary cilia length was similar in AMCF and 
NRCF. An around 2-fold increase could be detected in both cell types. 
 
Figure 26: Quantification of primary cilia frequency and length in AMCF after tubastatin A and 
LiCl treatment. 2D cardiac fibroblast cultures derived from adult mice (AMCF) were cultured for 24 
h in absence of serum and afterwards 6 µM tubastatin A (TubA) or 50 mM LiCl in serum-free medium 
was added. The cells were cultured for further 24 h. Acetylated α-tubulin was detected with a specific 
antibody. A) Fluorescence imaging was performed and the number of ciliated cells was counted and 
is given as fraction of all cells. B) The length of primary cilia was measured with the freehand line 
tool of Image J. Given are the means±SEM of three independent experiments (n=3). In each 
experiment a minimum of 507 cells and for length measurement a minimum of 16 cilia per condition 
were analysed, *p<0.05 assessed by one-way ANOVA. 
The observed differences between NRCF and AMCF raised the question whether this was 
due to a difference in species or developmental stage. Therefore, neonatal mouse cardiac 
fibroblasts were investigated in addition. By immunoblot analysis a similar difference in the 
ratio of acetylated α-tubulin to total α-tubulin between NMCF and NRCF was found as 
compared to AMCF and NRCF. In both mouse cardiac fibroblasts 3-fold more α-tubulin was 






Figure 27: Comparison of α-tubulin acetylation in NRCF and NMCF by immunoblot analysis. 
Serum-starved 2D cardiac fibroblast cultures derived from neonatal rats (NRCF) and neonatal mice 
(NMCF) were used for immunoblot analysis. Acetylated α-tubulin and total α-tubulin were detected 
with specific antibodies in cell lysates containing equal protein amounts. Shown are representative 
immunoblots (left) and the analysis of acetylated α-tubulin normalized by α-tubulin. The values are 
given as means±SEM relative to NRCF, n=3, significance was tested vs. NRCF assessed by 
unpaired t-test. 
Next, the NMCF were treated with tubastatin A and lithium chloride after starvation and α-
tubulin acetylation as well as primary cilia regulation was investigated. Tubastatin A 
increased α-tubulin acetylation by 15-fold and lithium chloride by 2.2-fold, which is more 
similar to the observed changes in AMCF than in NRCF. The fraction of ciliated NMCF was 
under basal condition around 60%, and declined in the presence of tubastatin A to 30%. 
Similar as shown for NRCF and AMCF, lithium chloride had no effect on the number of 
ciliated cells. Thus, the fraction of ciliated NRCF and NMCF was rather comparable. The 
measured mean primary cilia length was 0.6 µm under basal conditions and thus it was 
identical to the mean cilium length in AMCF. Lithium chloride treatment increased the mean 





Figure 28: Quantification of α-tubulin acetylation and of primary cilia frequency and length in 
NMCF treated with tubastatin A and LiCl. 2D cardiac fibroblast cultures derived from neonatal 
mice (NMCF) were cultured for 24 h in absence of serum and afterwards 5 µg/mL tubastatin A (TubA) 
or 6 µM LiCl in serum-free medium was added as indicated. The cells were cultured for further 24 h. 
A) By immunoblot analysis acetylated α-tubulin, total α-tubulin and β-actin were detected with 
specific antibodies in cell lysates containing equal protein amounts. Shown are representative 
immunoblots (left) and the analysis of acetylated α-tubulin normalized by α-tubulin. The values are 
given as means±SEM relative to untreated control, n=3, *p<0.05 vs. control assessed by one-way 
ANOVA. B) Acetylated α-tubulin was detected with a specific antibody. Fluorescence imaging was 
performed and the number of ciliated cells was counted and is given as fraction of all cells. n=2, 7 to 
8 images were analysed per experiment. Shown are the single measurements and the means.  
C) The length of primary cilia was measured with the freehand line tool of Image J. Given are the 




 Increased α-tubulin acetylation interferes with proliferation capacity of 
cardiac fibroblasts 
Primary cilia are post-mitotic cellular structures that are present in cells during G0/G1 and 
the beginning of S phase. They disassemble at late S to early G2 phase when the centriole 
in the basal body is used to organise the mitotic spindle (Rieder et al. 1979). Therefore, 
primary cilia regulation is tightly connected to cell cycle control. In order to investigate the 
effects of tubastatin A and lithium chloride on the ability of NRCF to divide, proliferation 
assays were performed. Under basal condition, the doubling time was around 70 hours in 
the presence of serum. Treatment with tubastatin A and lithium chloride both completely 
blocked cell proliferation. Four days of lithium chloride treatment resulted in a decline in cell 
number by around 30% compared to day 0 (Fig.29). 
 
Figure 29: Analysis of proliferation of NRCF under control conditions and after treatment with 
tubastatin A or LiCl. 2D cardiac fibroblast cultures derived from neonatal rats (NRCF) were cultured 
in medium containing 10% FCS and additionally 5 µg/mL tubastatin A (TubA) or 50 mM LiCl as 
indicated for up to 4 days. Nuclei were stained with DAPI and quantified by automated counting. The 
change in cell numbers are given relative to day 0 of each group and are shown are means±SEM, 
n=3, *p<0.05 vs. control at the respective time point. 
Next the proliferation capacity of AMCF was analysed. These cells grew very poorly even 
in the presence of serum and the estimated doubling time according to the data presented 
in figure 28 was around 200 hours. Treatment with tubastatin A and lithium chloride blocked 
cell proliferation. Four days of tubastatin A and lithium chloride treatment resulted in a 





Figure 30: Analysis of proliferation of AMCF under control conditions and after treatment with 
tubastatin A or LiCl. 2D cardiac fibroblast cultures derived from adult mice (AMCF) were cultured 
in medium containing 10% FCS and additionally 6 µM tubastatin A (TubA) or 50 mM LiCl as indicated 
for up to 4 days. Nuclei were stained with DAPI and quantified by automated counting. The change 
in cell numbers are given relative to day 0 of each group and are shown as means±SEM, n=3, 






 Do cardiac fibroblasts carry primary cilia? 
Primary cilia have been shown to be present in most mammalian cells (Miyoshi et al. 2011) 
but no data is available, whether these structures can be found on cardiac fibroblasts or 
not. At the beginning of this thesis, several criteria were considered to reduce the risk of 
falsely identifying cytoskeletal structures as primary cilia. First, for immunofluorescence 
experiments, a specific antibody against acetylated α-tubulin and not against total α-tubulin 
was used to better visualise the axoneme of primary cilia. In addition, γ-tubulin, which is an 
indispensable part of the cilium’s basal body (Kollman et al. 2010) was co-stained with 
acetylated α-tubulin. These stainings were then imaged by confocal microscopy to allow 
better resolution. By this, typical primary ciliary structures were found in neonatal rat cardiac 
fibroblasts (NRCF) located characteristically on top or close to the nucleus (Gerdes et al. 
2009). Furthermore, the mean length of these structures in cardiac fibroblasts was 1.6 µm 
in the presence and 2.72 µm in the absence of serum, which resembles the typical primary 
cilia length of 1-3 µm (Deane et al. 2013). Moreover, by showing that lithium chloride 
treatment increased the length of these structures in cardiac fibroblasts, their presence in 
these cells can be regarded as proven. 
Next, the dependence on species or maturation state was investigated by analysing human 
ventricular as well as neonatal and adult mouse cardiac fibroblasts (NMCF and AMCF) in 
addition. All of them were found to carry structures fulfilling the characteristics of primary 
cilia. Hence, it can be assumed, that the presence of primary cilia in cardiac fibroblasts in 
2D cultures is species and maturation state independent. Therefore, some of the further 
experiments were carried out only on NRCF, as we assumed that phenomena observed in 
these cells could are shared with other cardiac fibroblasts.  
Primary cilia and their presence as sensory organelles have been studied intensely in 
epithelial and endothelial cells, which are located on organ and vessel surfaces. In 2D 
cultures, cardiac fibroblasts were grown in a monolayer covered by the culture medium, 
which more resembles a surface environment than that of interstitial cells. Although primary 
cilia have been detected in other interstitial cells such as osteocytes (Spasic und Jacobs 
2017) as well as in 3D culture models of chondrocytes (McGlashan et al. 2010), their 
presence in matrix-embedded cardiac fibroblasts had not been demonstrated. Therefore, 
NRCF were embedded in a mesh of collagen 1, cultured for 5 days and acetylated α-tubulin 




also present in collagen-embedded cardiac fibroblasts and were not only an artefact of the 
potentially developed pseudo-polarity in 2D cultures.  
However, in this kind of engineered tissue, fibroblasts were not exposed to other cell types 
and thus conditions did not resemble those in the heart in vivo. Therefore, engineered heart 
muscles (EHM) composed of all cardiac cells were used as a heterogeneous 3D model. To 
assess the presence of primary cilia in EHM, the different cell types had to be distinguished 
from each other. The identification of cardiomyocytes is relatively uncomplicated. Their 
sarcomere structure can be easily identified by staining for F-actin and cell-specific markers, 
such as caveolin-3 (Song et al. 1996), which was used in the experiments of this thesis. 
The second most abundant cell type in the heart, endothelial cells (Pinto et al. 2016), could 
be differentiated using immunostaining for CD31. In the EHM endothelial cells formed tube-
like structures exhibiting a dotted pattern of CD31, likely marking adherence junctions 
(Privratsky and Newman 2014). Finally, the identification of cardiac fibroblasts was based 
on the exclusion principle. Cells negative for caveolin-3 and CD31 were considered as 
cardiac fibroblasts. Using this method it is not possible to distinguish between cardiac 
fibroblasts and smooth muscle cells. However detailed analysis of the cell composition used 
for EHM preparation (Naito et al. 2006) revealed that the majority of used non-myocytes 
were cardiac fibroblasts, which allowed us to use this model. Although no numerical data is 
available on the fraction of ciliated cells in EHM, the stainings clearly demonstrated that 
cardiomyocytes, displaying a certain degree of maturity as evaluated by caveolin-3 
expression (Lieu et al. 2009) did not carry primary cilia. This is in line with early findings on 
the presence of primary cilia in the human heart showing that in the embryonic myocardium 
primary cilia were detectable in myoblasts and rarely in defined cardiomyocytes, whereas 
in the adult heart, primary cilia were restricted to non-muscular cells of the myocardial layer 
(Myklebust et al. 1977). Cells forming the endothelial tubes or those which are attached to 
them were found occasionally to carry primary cilia in EHM. Endothelial cells of the aorta 
had been shown to carry primary cilia especially in areas of blood flow turbulences (Van der 
Heiden et al. 2008). These cilia, however, project into the vessel lumen and not towards the 
surrounding tissue as in case of the EHM. We were not able to show if this is because of 
the absence of flow in the EHM or because the cells which carry primary cilia are for 
example pericytes. Finally, the vast majority of the residual fraction of cells carried primary 
cilia in EHM. Although it is likely that most of these cells are indeed cardiac fibroblasts, 
future studies are needed to further characterise these cells e.g. by expression of periostin 
and TCF21 (Snider et al. 2008; Acharya et al. 2012). Moreover, the number of ciliated cells 




Our preliminary observations indicate that ciliary length seemed to be increased in 
embedded cells. This is in accordance with an observation of Xu and co-worker showing 
that type I collagen, which is the main component of the ECM in the heart and in the EHM, 
increased the primary cilia length of mouse embryo 3T3-L1 fibroblasts (Xu et al. 2017). 
Nevertheless, it needs to be taken into account that length measurements in 3D is a 
technical challenge. One possible methodological approach has been described by 
Saggese et al. which combines confocal imaging, deconvolution and Gaussian blurring to 
accurately measure the length of primary cilia in 3D culture (Saggese et al. 2012).  
 Primary cilia regulation in cardiac fibroblasts 
 HDAC6 inhibition reduces the number of primary cilia in cardiac 
fibroblasts 
Histone deacetylase 6 (HDAC6) is a class IIb deacetylase, which regulates the 
deacetylation of α-tubulin in cells (Hubbert et al. 2002). To study the role of HDAC6, different 
inhibitors are available of which tubastatin A shows so far the highest selectivity (Butler et 
al. 2010). In this thesis tubastatin A was used to study the effect of HDAC6 inhibition on 
primary cilia formation in cardiac fibroblasts. Immunoblot analysis revealed an over 10-fold 
increase in tubulin acetylation in all investigated cardiac fibroblast types, it was surprising 
to see that this uniformly resulted in a reduction of the fraction of ciliated cells. This is in 
sharp contrast to other studies showing that tubastatin A treatment increased the fraction 
of ciliated cholangiocarcinoma (Gradilone et al. 2013) and chondrosarcoma cells (Xiang et 
al. 2017). Moreover, knockdown of HDAC6 in immortalised RPE-1 (Pugacheva et al. 2007), 
mouse embryo fibroblast 3T3-L1 (Xu et al. 2016) and chondrosarcoma cells (Xiang et al. 
2017) prevented the reabsorption of primary cilia. Vice versa, the up-regulation of HDAC6, 
as for example found in osteoblasts treated with transforming growth factor β1 (TGF-β1), 
resulted in a reduced number of ciliated cells accompanied by a shortening and deformation 
of primary cilia (Ehnert et al. 2017). However, there are also studies showing on one hand 
that overexpression of HDAC6 in a human retinal pigment epithelial cell line led to a 
decrease in cilia length and number, but on the other hand neither the knockout nor the 
inhibition of HDAC6 by TubA had any influence on primary cilia formation (Ran et al. 2015). 
There is no data available demonstrating that HDAC6 inhibition decreases the number of 
ciliated cells. To further analyse this phenomenon, in this thesis the distribution of acetylated 
α-tubulin in cardiac fibroblasts was analysed. By immunofluorescence analysis, it was found 
that the acetylated α-tubulin was distributed all over the cells and not restricted to the 




explanation for this finding could lie in the distribution of HDAC6 itself. For RPE-1 cells it 
was shown that HDAC6 is distributed all over the cytoplasm and enriched at the basal body 
and the centrosome (Ran et al. 2015). The centrosomal distribution, however, depends on 
its regulation by the death inducer obliterator 3 (Dido3) (Sánchez de Diego et al. 2014). 
Whether HDAC6 indeed has a different localisation in cardiac fibroblasts, maybe due to its 
regulation by Dido3, has to be elucidated further. 
 LiCl increases primary cilia length in cardiac fibroblasts 
Lithium salts are used in the clinics as mood stabilisers to treat e.g. bipolar disorders. On a 
cellular level lithium was found to increase the length of primary cilia in many different cell 
types (Miyoshi et al. 2009; Thompson et al. 2016; Spasic und Jacobs 2017). Whether this 
could explain its pharmacological action is not known. On a molecular level several targets 
of lithium have been identified including glycogen synthase kinase 3β (GSK-3β) (Klein and 
Melton 1996), several adenylyl cyclases (AC), preferentially AC5 (Mann et al. 2009), but 
also ACIII which resides in the primary cilium (Ou et al. 2012; Antal et al. 2017)), and the 
inositol monophosphatase (IMPase) (Shaldubina et al. 2001). With respect to bipolar 
disorders, there are several lines of evidences that the inhibitory effect of lithium on GSK-
3β is responsible for its pharmacological action (Muneer 2017). The inhibitory mechanism 
of lithium on GSK-3β seems to be complex. On one hand a direct mechanism was proposed 
in which the lithium ion replaces the essential magnesium ion which may influence the 
phosphoryl transfer to substrates (Ryves und Harwood 2001). On the other hand lithium 
was demonstrated to increase phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) 
activity, leading to an inhibition of GSK-3β by phosphorylation of serine 9 via Akt activation 
(Chalecka-Franaszek and Chuang 1999).  
In line with several other publications demonstrating that lithium chloride increases the 
length of primary cilia in fibroblasts or fibroblasts-like cells (Nakakura et al. 2015; Spasic 
und Jacobs 2017), the treatment of cardiac fibroblasts with lithium chloride in 2D and 3D 
cultures resulted in an elongation of primary cilia by around 2-fold , independent of their 
source and whether serum was present or not. The open question which remains is how 
this elongation is regulated in detail. A potential mechanism is the lithium chloride-
dependent inhibition of GSK-3β, which had been assessed in other cells not only by lithium 
chloride, but also by the use of more specific tools. For example, in N1 murine hypothalamic 
neuronal cells it had been demonstrated that the knockdown of GSK-3β by a specific siRNA 
resulted in primary cilia elongation (Kang et al. 2015). In human retinal pigmented 




mts peptide inhibitor was found to increase ciliary length similar as lithium did (Ou et al. 
2012). However, there are also contradictory findings showing e.g. that in contrast to lithium 
four different GSK-3β inhibitors (valproate, GSK-3β inhibitor II, VII and XI) did not have any 
effect on cilia length in human fibroblast-like synoviocytes (Ou et al. 2009). And in mouse 
embryonic fibroblasts and in murine NIH 3T3 fibroblasts the knockout of GSK-3β as well as 
its inhibition by CHIR99021 resulted even in an inhibition of primary cilia formation (Zhang 
et al. 2015).  
The role of GSK-3β in the regulation of primary cilia formation and elongation is 
controversially discussed, and potential down-stream mechanisms are unclear. In N1 
murine hypothalamic neuronal cells it was shown that overexpression of GSK-3β led to a 
down-regulation of ciliary genes such as KIF3A and several IFT-genes. (Kang et al. 2015). 
For human fibroblast KD cells it was suggested that inhibition of GSK-3β by lithium chloride 
mobilises the α-tubulin-N-acetyl-transferase (ATAT1), which leads to increased acetylation 
of α-tubulin and to elongation of primary cilia. However, this hypothesis mainly relies on 
data showing that the knockout of ATAT1 by a siRNA reduced α-tubulin acetylation whereas 
inhibition of GSK-3β increased it (Nakakura et al. 2015). In primary mouse embryonic 
fibroblasts (MEFs) it was shown that only the combined inactivation of the gene product of 
the Von-Hippel-Lindau tumour suppressor gene (pVHL) and of GSK-3β led to a reduction 
of the fraction of ciliated cells. The inactivation of only one of those two factors was not 
sufficient to affect cilia maintenance (Thoma et al. 2007).  
Taken together, the data in this thesis clearly demonstrates that primary cilia elongation in 
cardiac fibroblasts is sensitive to lithium chloride treatment, however, whether or not this 
involves the inhibition of GSK-3β and/or the mobilisation of ATAT1 requires further 
investigation. 
 Hypoxia increases primary cilia length 
Hypoxia is a pathologic condition which occurs in the heart either as an immediate 
consequence e.g. of a coronary artery occlusion or chronically as a result of cardiac fibrosis 
leading to an insufficient perfusion of the myocardium. Hypoxia affects all cells in the heart 
including cardiac fibroblasts, which transdifferentiate into myofibroblasts (Watson et al. 
2014). This induces, in case of a myocardial infarction, the induction of reparative fibrosis 
in order to produce a stable scar.  
The effect of hypoxia on cardiac fibroblast behaviour has been also studied in 2D culture 




fibroblasts. This e.g. includes the production of ECM proteins and cell proliferation (Gao et 
al. 2014; Ugolini et al. 2017). In this thesis, the elongation of primary cilia of cardiac 
fibroblasts as a consequence of hypoxia could be observed.  
The central molecule in the transmission of hypoxia into a biological response is the 
transcription factor HIF-1α. Under normoxic conditions HIF-1α is hydroxylated by prolyl 
hydroxylases (PHD), leading to binding of pVHL and consequently to its ubiquitination and 
proteasomal degradation (Metzen und Ratcliffe 2004). As already mentioned above, pVHL 
plays a role in the regulation of primary cilia formation. Patients having mutations in pVHL 
are predisposed to certain cancer types, including renal cancer of the clear cell type (CC-
RCC), thus pVHL acts in addition as a tumour suppressor gene. Interestingly, established 
cancer cell lines from CC-RCC patients are missing primary cilia and are often used to study 
the role of pVHL in this context. In these cell lines it was further shown that loss-of-function 
mutations in pVHL led to the accumulation of HIF-1α (Esteban et al. 2006; Xu et al. 2010), 
raising the question whether HIF-1α is needed for primary cilia regulation. By induction of 
hypoxia and by the use of specific siRNAs against HIF-1α or by its overexpression in 
normoxia most studies could establish a role of this transcription factor in primary cilia 
regulation, not only in RCC cells, but also in other cell types including mouse embryonic 
fibroblasts and mesenchymal stem cells (Esteban et al. 2006; Xu et al. 2010; Proulx-
Bonneau und Annabi 2011; Troilo et al. 2014). However, these studies uniformly show that 
HIF-1α inhibits primary cilia formation, in sharp contrast to the finding in this current thesis. 
There was no difference in the proportion of ciliated cells under normoxic and hypoxic 
control conditions eitherin the presence or absence of lithium chloride. Only when HDAC6 
was inhibited, less cells were found to carry primary cilia in hypoxia. This data argues for a 
link between hypoxia and HDAC6 in the regulation of primary cilia. And indeed it was shown 
that HDAC6 can stabilise HIF-1α (Kong et al. 2006; Qian et al. 2006) and that HIF-1α 
regulates Aurora kinase A expression (Klein et al. 2008; Dere et al. 2015). Aurora kinase A 
plays not only a role in cell cycle regulation, but can induce fast primary cilia reabsorption 
by phosphorylation and thus activation of HDAC6 at the basal body of primary cilia. 
Interestingly, Aurora kinase A is not only regulated by hypoxia, but also by serum via the 
human enhancer of filamentation 1 (HEF1) (Pugacheva et al. 2007).  
Data concerning a possible connection between primary cilia elongation and stabilisation of 
HIF-1α, as found in this thesis, had been rarely described by others. It had been shown, 
that in mice upon renal injury and under the resulting hypoxic condition, primary cilia in the 




2008). In Madin Darby canine kidney cells those findings could be confirmed by stabilising 
HIF-1α via treatment with cobalt chloride (Verghese et al. 2011). Our data on primary cilia 
in cardiac fibroblasts and HIF-1α stabilisation upon hypoxic conditions resemble the findings 
of Verghese et al. Nevertheless, further investigations are required, to clarify how HIF-1α 
facilitates the elongation of primary cilia in cardiac fibroblasts. One explanation for a HIF-
1α-dependent elongation of primary cilia could lie in its inhibition of GSK-3β. In line with this 
hypothesis, Lal and colleagues demonstrated that isolated cardiac fibroblasts from ischemic 
mouse hearts showed a 2-fold increase in GSK-3β phosphorylation at its inhibitory serine 9 
(Lal et al. 2014). In summary, it can be considered as possible that there are overlaps in 
the effects of lithium chloride and hypoxia. But since we found, that under hypoxic conditions 
lithium chloride still leads to an elongation of primary cilia in comparison to primary cilia of 
cardiac fibroblasts under hypoxic control conditions, it is likely that the underlying 
mechanism is not identical. 
 Primary cilia and cardiac fibroblast proliferation 
The formation of primary cilia is restricted to cells in cell cycle phase G1/G0, since they 
originate from the mother-centriole (Marshall 2007). The latter is part of the spindle-
apparatus formed during mitosis and therefore not available for primary cilia formation when 
cells divide. Surprisingly, we could not determine a difference in the fraction of ciliated cells 
in NRCF in the absence or presence of 10% serum, which had been shown to be a 
proliferation stimulus for those cells (Jatho et al. 2015).  
We found that lithium chloride has an impact on primary cilia and on proliferation in cardiac 
fibroblasts, which raises the question if a correlation between both can be determined. The 
effect of lithium chloride treatment was restricted to the length of primary cilia, whereas the 
fraction of ciliated cells did not change significantly. Based on these data we do not expect 
that the antiproliferative effect of lithium chloride treatment is based on its influence on 
primary cilia. It is more likely that either the increased tubulin acetylation or another 
mechanism underlies the impaired proliferation rate of cardiac fibroblasts treated with 
lithium chloride. In human Tenon’s capsule fibroblasts lithium chloride has been shown to 
inhibit TGF-β1-induced expression of α-smooth muscle actin (Chung et al. 2014). As 
described in section 1.1, TGF-β1 is involved in the activation of fibroblasts to α-smooth 
muscle actin expressing myofibroblasts, which have a considerably higher proliferation 
capacity than quiescent fibroblasts. In inhibiting the TGF-β1-mediated activation, the 




In addition, the effects of tubastatin A and lithium chloride in cardiac fibroblasts were similar 
concerning their effect on cell proliferation, but different concerning primary cilia length. 
Those findings argue for different mechanisms underlying the effects of the treatments on 
primary cilia and proliferation.  
Even though we did not show a direct interaction between primary cilia in cardiac fibroblasts 
and the proliferation rate of those cells, primary cilia and proliferation cannot be assessed 
independently. In various other cell types a connection has been shown, such as the 
uncontrolled proliferation of kidney cells of patients affected by the ciliopathy polycystic 
kidney disease (PKD) (Nauli et al. 2003). Other examples are the loss of primary cilia in 
pancreatic cancer cells (Seeley et al. 2009) or in cholangiocarcinoma cells (Gradilone et al. 
2013). Thus, further investigations concerning the influence of primary cilia in cardiac 
fibroblasts on proliferation and fibrosis development are needed.  
 The potential function of primary cilia in cardiac fibroblasts 
The function of primary cilia in cardiac fibroblasts is far from being defined. Nevertheless, 
reasonable hypotheses can be proposed. In the beating heart, cardiac fibroblasts are 
exposed to a cyclic strain and possess the ability to react to relative changes of strain in the 
cardiac wall. To assess whether primary cilia as sensory organelles play a role in the 
perception of those changes, a method to subject cardiac fibroblasts to cyclic strain could 
be used.  
To this end, in the chondrocytes system, flexible-bottomed culture plates have been used 
and a cyclic tensile strain of 10% and 20% at 0.33 Hz has been applied. This experiment 
revealed that primary cilia in chondrocytes are shortened under application of cyclic tensile 
strain (Thompson et al. 2014). Another published example of the influence of tensile stress 
on cilia length is the elongation of tendon cell cilia upon stress-deprivation (Gardner et al. 
2011). We suggest to investigate the effect of strain on primary cilia in cardiac fibroblasts in 
2D by the use of the flexible-bottomed culture plates and in 3D by stretching engineered 
tissue (ECT and EHM) with different amplitudes and different frequencies of cyclic strain 
and visualising the changes in primary cilia performance by immunofluorescence.  
In addition, a chemosensory function of primary cilia in cardiac fibroblasts is possible. The 
entry of proteins at the base of the cilium in a concentration- and size-dependent manner 
has been demonstrated (Lin et al. 2013). The entry was impeded with increasing protein 
size. In the development of fibrosis several cytokines play an important role, such as TGF-




triggered by cytokines and it is possible, that primary cilia are involved in the process of 
detecting and reacting to cytokine stimuli.  
 Limitations and perspectives 
The investigations concerning cardiac fibrosis and its key player, the cardiac fibroblast, have 
been limited in the past inter alia by the lack of a specific fibroblast marker. With the 
availability of new, more specific markers such as TCF21 (Acharya et al. 2012) and 
PDGFRα (Moore-Morris et al. 2014), novel approaches will be facilitated, including studies 
not only of engineered, but of natural heart muscle. Hence, in order to complete the 
evaluation of the presence of primary cilia in cardiac fibroblasts, sections of healthy and 
diseased hearts should be examined by the help of these marker proteins.  
This project revealed that primary cilia length in cardiac fibroblasts can be regulated by 
lithium chloride and hypoxia. So far, the mechanisms behind the effects of lithium chloride 
and of HIF-1α on primary cilia length are not fully understood. A role of GSK-3β in both 
regulations is however likely, as discussed above. Therefore, specific GSK-3β inhibitors 
should be included in future studies for verification. Moreover, the role of HDAC6 in primary 
cilia regulation differs from otherwise published data. One explanation could lie in a different 
localisation of HDAC6 in cardiac fibroblasts compared to other cells. Detailed 
immunofluorescence analyses could help to shed light on this contradictory result.  
Finally, independent of their impact on primary cilia number and shape, both lithium chloride 
and HDAC6 inhibition resulted in a compete suppression of cardiac fibroblast proliferation. 
The remaining question is whether HDAC6 inhibition or lithium chloride could potentially 
prevent cardiac fibroblast proliferation in the diseased heart and thus prevent cardiac 
fibrosis. Tubastatin A has not been tested in humans yet. In animal models the data are so 
far not conclusive. In mice a general knockout of HDAC6 was found to improve the cardiac 
contractile function after chronic angiotensin II administration, however, cardiac fibrosis was 
strongly increased compared to wild type mice (Demos-Davies et al. 2014). In contrast, in 
rats the inhibition of HDAC6 with tubastatin A led to a reduction in kidney fibrosis after 
angiotensin II administration (Choi et al. 2015).  
Lithium on the other hand is a well-known neuro-psychiatric drug, which has been used for 
many years including today, as a mood-stabiliser in the treatment and prophylaxis of bipolar 
disease (Shaldubina et al. 2001). Even though lithium has a narrow therapeutic index, a lot 
of clinical experience in its use already exists. Nevertheless, one potential side effect of 




along with remodelling of the tissue including interstitial kidney fibrosis (Walker et al. 1982). 
Moreover, lithium was shown to have the propensity to induce arrhythmias. 
Contraindications for lithium treatment are therefore e.g. changes in the ECG like QT-
prolongations as well as heart failure, disqualifying lithium as a suitable therapy for cardiac 
fibrosis. 
 Conclusion 
The data obtained in this study provide evidence, that primary cilia are present in cardiac 
fibroblasts from different origins in homogenous 2D as well as in rat homo- and 
heterogenous 3D cultures. The fraction of cells carrying primary cilia are reduced by HDAC6 
inhibition with tubastatin A and primary cilia length was increased by lithium chloride and 
hypoxia. An increase in tubulin acetylation induced by tubastatin A or lithium chloride led in 






Cardiac fibroblasts and their activation upon cardiac damage play a key role in pathological 
cardiac remodelling and the development of cardiac fibrosis. This thesis investigates the 
role of α-tubulin acetylation in cardiac fibroblasts with a special focus on formation and 
regulation of primary cilia. The primary cilium is a microtubule-based, immotile sensory 
structure, that contains acetylated α-tubulin. 
First, the presence of primary cilia in cardiac fibroblasts in 2D culture of neonatal rat cardiac 
fibroblasts (NRCF), neonatal and adult mouse cardiac fibroblasts (NMCF, AMCF) and 
human ventricular cardiac fibroblasts (HVCF) was shown by immunofluorescence. This 
leads to the conclusion that cardiac fibroblasts from different species and maturation states 
possess primary cilia.  
Two 3D models were used to assess primary cilia: engineered connective tissue, in which 
cardiac fibroblasts are embedded in collagen I, as well as engineered heart muscle, which 
are composed of all cardiac cells surrounded by a collagen I matrix. Primary cilia were found 
in cardiac fibroblasts in immunostainings of sections of ECT and EHM. 
In a next step the regulation of primary cilia in cardiac fibroblasts was examined by the use 
of two substances, which had been shown to increase the acetylation of α-tubulin; tubastatin 
A (TubA) and lithium chloride (LiCl). Tubastatin A is a specific inhibitor of HDAC6, the main 
deacetylase of α-tubulin. Lithium chloride leads to elevated levels of α-tubulin-acetylation 
by a mechanism that is not fully elucidated, but which probably involves the mobilisation of 
the α-tubulin-N-acetyltransferase (ATAT1), which catalyses the transfer of acetyl groups on 
α-tubulin. In immunoblot analysis the increased α-tubulin-acetylation following both 
treatments (TubA, LiCl) could be shown in NRCF, NMCF and AMCF. 
It was found, that treatment with lithium chloride significantly increases the length of primary 
cilia. The exact mechanism by which lithium chloride leads to an elongation of primary cilia 
is not clear but it is likely that this effect is mediated via inhibition of the glycogen synthase 
kinase 3 β (GSK-3β). 
One condition to which cells in the heart are exposed to during pathological processes such 
as myocardial infarction, is hypoxia. Hypoxic conditions were successfully induced in 
neonatal rat cardiac fibroblasts, as shown by the stabilisation of hypoxia inducible factor 1α 




chloride and it was found that hypoxia increases primary cilia length under control 
conditions, as well as in the presence of lithium chloride. 
Finally, the impact of both treatments on proliferation of NRCF and AMCF was investigated 
and it could be shown, that the proliferation capacity of cells with an increased α-tubulin 
acetylation was impaired. 
7 Zusammenfassung 
Kardiale Fibroblasten und ihre durch kardiale Schädigung hervorgerufene Aktivierung 
spielen eine Schlüsselrolle im Prozess des kardialen Umbaus und der Entwicklung kardialer 
Fibrose.  
Die vorliegende Dissertation befasst sich mit der Rolle der Acetylierung von α-Tubulin in 
kardialen Fibroblasten mit besonderem Augenmerk auf die Bildung und Regulation von 
Primärzilien. Die Primärzilie ist eine aus Mikrotubuli bestehende, unbewegliche sensorische 
Struktur, die acetyliertes α-Tubulin enthält. 
Zunächst wurde mittels Immunfluoreszenz gezeigt, dass 2D-Kulturen kardialer Fibroblasten 
von neonatalen Ratten (NRCF), neonatalen und adulten Mäusen (NMCF, AMCF) ebenso 
wie 2D-Kulturen humaner ventrikulärer kardialer Fibroblasten (HVCF) Primärzilien 
enthalten. 
Zusätzlich wurden zwei 3D-Modelle genutzt, um Primärzilien zu untersuchen: Engineered 
Connective Tissue, in dem die kardialen Fibroblasten in Kollagen I eingebettet sind, sowie 
Engineered Heart Muscle, welcher aus allen kardialen Zellen besteht, die ebenfalls in einer 
Matrix aus Kollagen I eingebettet sind. Primärzilien konnten mittels Immunfluoreszenz in 
Schnitten beider künstlicher Gewebe detektiert werden. 
Im nächsten Schritt wurde die Regulation der Primärzilien in kardialen Fibroblasten unter 
Einsatz zweier Substanzen betrachtet, die nachweislich die Acetylierung von α-Tubulin 
erhöhen: Tubastatin A (TubA) und Lithiumchlorid (LiCl). Tubastatin A ist ein spezifischer 
Inhibitor von HDAC6, der wichtigsten Deacetylase von α-Tubulin. Bei Lithiumchlorid handelt 
es sich um eine Substanz, die die α-Tubulin-Acetylierung durch einen bisher noch 
unvollständig verstandenen Mechanismus erhöht, welcher wahrscheinlich die Mobilisation 
der α-Tubulin-N-Acetyltransferase (ATAT1) involviert, die den Transfer von Acetylgruppen 
auf α-Tubulin katalysiert. Beide Behandlungen (TubA, LiCl) erhöhten die α-Tubulin-
Acetylierung sowohl in NRCF, NMCF als auch in  AMCF, wie mittels Immunoblot-Analyse 




Des Weiteren wurde festgestellt, dass die Behandlung mit Lithiumchlorid die Länge der 
Primärzilien erhöht. Obwohl der genaue Mechanismus, der zu dieser Verlängerung der 
Primärzilien führt, noch nicht geklärt ist, kann es als wahrscheinlich angesehen werden, 
dass der Effekt durch die Inhibition der Glykogen-Synthase-Kinase 3β vermittelt wird.  
Während pathologischer Prozesse, wie beispielsweise einem Myokardinfarkt, ist das Herz 
einem Sauerstoffmangel ausgesetzt. Hypoxische Bedingungen wurden erfolgreich in 
kardialen Fibroblasten neonataler Ratten induziert, wie die Stabilisierung des hypoxia 
inducible factor 1α (HIF-1α) zeigt. Unter den hypoxischen Bedingungen wurden die Zellen 
wiederum mit Tubastatin A und Lithiumchlorid behandelt, und es konnte festgestellt werden, 
dass Hypoxie sowohl unter Kontrollbedingungen als auch unter Lithiumchlorid-Behandlung 
zu einer Verlängerung der Primärzilien führt.  
Schließlich wurden die Auswirkungen beider Behandlungen auf die Zellproliferation von 
NRCF und AMCF untersucht, und es konnte gezeigt werden, dass die 
Proliferationsfähigkeit von Zellen mit einer erhöhten Acetylierung von α-Tubulin-
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